<?xml version="1.0" encoding="utf-8"?>
<search>
  
  
  
  <entry>
    <title>log</title>
    <link href="/2025/06/24/log/"/>
    <url>/2025/06/24/log/</url>
    
    <content type="html"><![CDATA[<p><strong>2025&#x2F;06&#x2F;24</strong></p><p>Finishing the background research of the DNA methylation and Neurodegenrative disease, Finishing the Introduction writing, begin to investigate how to use databse to identify the DMRs in the brain between the experiment and control group. </p><p>Apparent difference in the temporal lobe notice in AD for cg16867657</p><p>wanting to find a method, like searching for all case about methylation information comparison about alzheimer disease and normal people</p><p>then detecting several location for up or down regulation about DNA methylation. </p><p>è€ƒè™‘ç ”ç©¶æµç¨‹</p><table><thead><tr><th>æ­¥éª¤</th><th align="left">å†…å®¹</th></tr></thead><tbody><tr><td>1</td><td align="left">é€‰æ‹© GSE212682ï¼ˆ47äººè„‘ç»„ï¼‰</td></tr><tr><td>2</td><td align="left">ä¸‹è½½ <code>.idat</code> + metadata</td></tr><tr><td>3</td><td align="left">R åŒ…å¯¼å…¥ &amp; QC</td></tr><tr><td>4</td><td align="left">æ ‡å‡†åŒ–ï¼ˆFunnormï¼‰ + Beta&#x2F;Mvalè®¡ç®—</td></tr><tr><td>5</td><td align="left">æ‰¹æ¬¡æ•ˆåº”æ ¡æ­£</td></tr><tr><td>6</td><td align="left">DMPs å·®å¼‚åˆ†æï¼ˆlimmaï¼‰</td></tr><tr><td>7</td><td align="left">DMRs æ£€æµ‹ï¼ˆDMRcateï¼Œ DMRåæ¨åŸºå› ä½ç‚¹</td></tr><tr><td>8</td><td align="left">æ³¨é‡Šã€ç«å±±å›¾ã€çƒ­å›¾</td></tr><tr><td>9</td><td align="left">å¯Œé›† + è¡¨è¾¾æ•´åˆ + meQTLï¼Œ å¯Œé›†åˆ†æå®Œè¿›è¡Œmultiomicsåˆ†æ</td></tr><tr><td>10</td><td align="left">è®ºè¯ç ”ç©¶æ–°é¢–æ€§ä¸ç‹¬ç«‹æ€§</td></tr></tbody></table><p><strong>GSE66351</strong>ï¼šæ¥è‡ªå¤§è„‘åˆ†ç¦»çš„ç¥ç»å…ƒå’Œèƒ¶è´¨ç»†èƒçš„450kç”²åŸºåŒ–æ•°æ®ï¼ŒåŒ…æ‹¬ AD ä¸è¡°è€ç›¸å…³ä¿¡å·ï¼Œä½†ä¸»è¦é›†ä¸­äºç»†èƒç±»å‹å·®å¼‚ï¼Œæœªç³»ç»Ÿå¼€å±• DMP&#x2F;DMR EWAS <a href="https://alzres.biomedcentral.com/articles/10.1186/s13195-023-01232-7?utm_source=chatgpt.com">alzres.biomedcentral.com+1en.wikipedia.org+1</a><a href="https://www.omicsdi.org/dataset/geo/GSE66351?utm_source=chatgpt.com">biogps.org+3omicsdi.org+3europepmc.org+3</a>ã€‚</p><p>**E-GEOD-45775 (GSE45775)**ï¼šæµ·é©¬ä½“ä¸åŒ Braak åˆ†æœŸä¸‹ 27k ç”²åŸºåŒ–æ•°æ®ï¼ˆå…±20æ ·æœ¬ï¼‰ï¼Œå‰æœŸåªæ˜¯ç®€å•æè¿°ï¼Œä¸åŒ…å«å®Œæ•´å·®å¼‚åˆ†æ <a href="https://www.omicsdi.org/dataset/biostudies-arrayexpress/E-GEOD-45775?utm_source=chatgpt.com">biogps.org+2omicsdi.org+2omicsdi.org+2</a>ã€‚</p><p><strong>GSE41826</strong>ï¼šå…¬å…±åˆ†ç¦»çš®å±‚ç¥ç»å…ƒ450kæ•°æ®ï¼ˆå¥åº·ä¸ AD æ ·æœ¬ï¼‰ï¼Œåœ¨æ–¹æ³•æ¯”è¾ƒä¸­ä½¿ç”¨ï¼Œä½†æœªä½œä¸ºç‹¬ç«‹ EWAS åˆ†æç„¦ç‚¹ ã€‚</p><p><strong>GSE59685</strong>ï¼šå­¤ç«‹çš®å±‚&#x2F;æµ·é©¬450kæ•°æ®ï¼Œå·²ç”¨äºæ¯”å¯¹ä½†æœªè¿›è¡Œç—…ä¾‹â€”å¯¹ç…§ä¸»æ•ˆåº” EWAS <a href="https://epigeneticsandchromatin.biomedcentral.com/articles/10.1186/s13072-018-0211-3?utm_source=chatgpt.com">pubmed.ncbi.nlm.nih.gov+15epigeneticsandchromatin.biomedcentral.com+15alzres.biomedcentral.com+15</a>ã€‚</p><p><strong>GSE80970</strong>ï¼šPituitary æˆ–é¢å¶çš®å±‚450kæ•°æ®ï¼Œä½œä¸ºæ‰¹æ¬¡æ¯”è¾ƒä½¿ç”¨ï¼Œä½†ç¼ºå°‘ AD vs æ§åˆ¶ EWAS <a href="https://epigeneticsandchromatin.biomedcentral.com/articles/10.1186/s13072-018-0211-3?utm_source=chatgpt.com">epigeneticsandchromatin.biomedcentral.com+1europepmc.org+1</a>ã€‚</p><p><strong>GSE98203</strong>ï¼šNeun+ åˆ†ç¦»é¢å¶ç¥ç»å…ƒ450kæ•°æ®ï¼ˆ28 ä¾‹å¥åº·ï¼‰ï¼ŒæœªåŒ…å« AD ç—…äººåˆ†æ <a href="https://epigeneticsandchromatin.biomedcentral.com/articles/10.1186/s13072-018-0211-3?utm_source=chatgpt.com">epigeneticsandchromatin.biomedcentral.com</a>ã€‚</p><p><strong>GSE156984</strong>ï¼šEPIC æ•°æ®é›†ï¼Œç ”ç©¶è€…å·²å‘å¸ƒä¸ AD å…³è” CpG&#x2F;DMR å…±è¯†ï¼Œä½†éƒ¨åˆ†åŒºåŸŸå°šæœªå…¨æ–‡åˆ†æ <a href="https://clinicalepigeneticsjournal.biomedcentral.com/articles/10.1186/s13148-020-00944-z?utm_source=chatgpt.com">arxiv.org+15clinicalepigeneticsjournal.biomedcentral.com+15alzres.biomedcentral.com+15</a>ã€‚</p><p><strong>Bulk è„‘åŒº 47 æ ·æœ¬å¤šè„‘åŒº EPIC æ•°æ®</strong>ï¼ˆActa Neuropathologica CommunicationsæåŠï¼‰ï¼šåŒ…å«8ä¸ªè„‘åŒº AD vs å¯¹ç…§æœªæ·±å…¥EWAS <a href="https://actaneurocomms.biomedcentral.com/articles/10.1186/s40478-022-01470-0?utm_source=chatgpt.com">arxiv.org+4actaneurocomms.biomedcentral.com+4en.wikipedia.org+4</a>ã€‚</p><p><strong>ROSMAP DLPFC DNA ç”²åŸºåŒ– + è¡¨è¾¾æ•°æ®</strong>ï¼šé“¾æ¥äºHuman Molecular Genetics MRç ”ç©¶ï¼Œæ•°æ®å­˜åœ¨ä½†æœªå•ç‹¬è¿›è¡Œ EWAS å·®å¼‚å‘ç° ã€‚</p><p><strong>GSE109887</strong>ï¼šä¸­é¢å¶è„‘ç»„ç»‡ä¸è¡€æ¶²450k&#x2F;HO methylation æ•°æ®ï¼Œå·²æœ‰è¡¨è¾¾å…³è”åˆ†æä½†æœªå®Œæ•´EWAS</p><p><strong>MethyLogiX</strong>ï¼šä¸“æ³¨21&#x2F;22æŸ“è‰²ä½“å’Œ ADï¼Œå«è€å¹´é—ä¼ ç”²åŸºåŒ–èµ„æ–™</p><p>GSE109627ï¼‹GSE109887ï¼šä¸­é¢å¶450k+RNA-seqå…¸å‹ADå¤šç»„å­¦æ•´åˆå­¦ä¹ æ¡ˆä¾‹</p><p>GSE66351 + GSE80970ï¼šè„‘ç»„ç»‡450kæ•°æ®æ”¯æŒSVMåˆ†ç±»ï¼Œå°šæœªç³»ç»ŸEWAS</p><p>**AddNeuroMed è¡€æ¶²ç”²åŸºåŒ– GSE??**ï¼šé¦–ä¸ªå¤§è§„æ¨¡AD&#x2F;MCIè¡€æ¶²EWASï¼Œé‡ç‚¹HOXB6åŒºåŸŸ</p><p><strong>Parkinson WGBS &#x2F; MSRE NGS</strong>ï¼šNGS ç”²åŸºåŒ–æµ‹åºæ•°æ®å°‘è§ PD EPIC å¯è¡¥å¼ºã€‚</p><p>**BloodParkinson (GSE111629)**ï¼š563 è¡€æ¶²æ ·æœ¬ï¼Œå¯ EWAS PD è¡€æ¶²</p><p>**DLBepigenetics (GSE190348)**ï¼šLewy body ç—…ä¾‹è„‘ EPIC æ•°æ®ï¼Œå¯äº¤å‰ PD åˆ†æ</p><p><strong>RnBeads Methylome Resource</strong>ï¼šWGBS + RRBS + 450kï¼Œ4000+ æ ·æœ¬ï¼Œå¯è¡¥è„‘åŒºèµ„æ–™</p><p><strong>EWAS Data Hub</strong>ï¼š75k+ æ ·æœ¬ï¼Œ25 è„‘åŒºï¼Œ39 ç–¾ç—…ï¼Œæ•°æ®å¯è‡ªå®šä¹‰æŠ½å–  </p><table><thead><tr><th>æ•°æ®åº“</th><th>æ•°æ®é›†ç¼–å·</th><th>ç‰©ç§</th><th>ç»„ç»‡</th><th>æ ·æœ¬æ•°ï¼ˆç—…ä¾‹&#x2F;å¯¹ç…§ï¼‰</th><th>æ•°æ®ç±»å‹</th><th>å¤‡æ³¨</th></tr></thead><tbody><tr><td>GEO</td><td><strong>GSE153712</strong></td><td>äººç±»</td><td>å¤§è„‘ï¼ˆå‰é¢å¶çš®å±‚ï¼‰</td><td>42 (21 AD &#x2F; 21 Ctrl)</td><td>EPIC 450k <code>.idat</code></td><td>è„‘ç»„ç»‡ç”²åŸºåŒ–æ•°æ®ï¼Œé€‚åˆè„‘éƒ¨è¡¨è§‚é—ä¼ ç ”ç©¶</td></tr><tr><td>GEO</td><td><strong>GSE109627</strong></td><td>äººç±»</td><td>å¤§è„‘ï¼ˆé¢å¶çš®å±‚ï¼‰</td><td>76 (40 AD &#x2F; 36 Ctrl)</td><td>450k <code>.idat</code></td><td>åŒ…å«ç”²åŸºåŒ–å’Œè¡¨è¾¾æ•°æ®ï¼Œæ–¹ä¾¿multi-omicsæ•´åˆ</td></tr><tr><td>GEO</td><td><strong>GSE80970</strong></td><td>äººç±»</td><td>å¤§è„‘ï¼ˆæµ·é©¬ï¼‰</td><td>38 (18 AD &#x2F; 20 Ctrl)</td><td>450k <code>.idat</code></td><td>å°æ ·æœ¬ä½†è„‘ç»„ç»‡ï¼Œé€‚åˆéªŒè¯</td></tr><tr><td>GEO</td><td><strong>GSE111629</strong></td><td>äººç±»</td><td>è¡€æ¶²</td><td>563 (PD + å¯¹ç…§æ··åˆ)</td><td>450k <code>.idat</code></td><td>Parkinson è¡€æ¶²ç”²åŸºåŒ–ï¼Œæ ·æœ¬å¤§</td></tr><tr><td>NIAGADS</td><td>AMP-AD ROSMAP</td><td>äººç±»</td><td>å¤§è„‘ï¼ˆDLPFCï¼‰</td><td>700+</td><td>EPIC&#x2F;450k &amp; RNA-seq</td><td>å¤šç»„å­¦ä¸°å¯Œï¼Œå«ç”²åŸºåŒ–å’Œè¡¨è¾¾ï¼Œé€‚åˆå¤šç»„å­¦æ•´åˆåˆ†æ</td></tr><tr><td>GEO</td><td><strong>GSE145361</strong></td><td>äººç±»</td><td>è„‘ï¼ˆå¤šä¸ªè„‘åŒºï¼‰</td><td>68 (AD)</td><td>EPIC <code>.idat</code></td><td>å¤šè„‘åŒºï¼Œå«å¤§è„‘çš®å±‚ä¸æµ·é©¬</td></tr><tr><td>GEO</td><td><strong>GSE72778</strong></td><td>äººç±»</td><td>è¡€æ¶²</td><td>20 (PD)</td><td>450k <code>.idat</code></td><td>Parkinson è¡€æ¶²ç”²åŸºåŒ–ï¼Œæ•°æ®å¯è¡¥å……</td></tr></tbody></table><p>ä¸­è„‘ç»„ç»‡é¢å¤–åˆ†æ</p><p>åˆ†ææµç¨‹ï¼š</p><hr><h2 id="ğŸ”¹-Step-1-æ•°æ®è·å–ä¸å‡†å¤‡"><a href="#ğŸ”¹-Step-1-æ•°æ®è·å–ä¸å‡†å¤‡" class="headerlink" title="ğŸ”¹ Step 1. æ•°æ®è·å–ä¸å‡†å¤‡"></a>ğŸ”¹ Step 1. æ•°æ®è·å–ä¸å‡†å¤‡</h2><ul><li><strong>ç›®æ ‡</strong>ï¼šè·å–è´¨é‡å¯æ§ã€è„‘åŒºæ˜ç¡®ã€AD&#x2F;Control æ˜ç¡®çš„ DNA ç”²åŸºåŒ–åŸå§‹æ•°æ®ã€‚</li><li><strong>æ¥æº</strong>ï¼š<ul><li>GEOï¼ˆå¦‚ GSE153712, GSE109887 ç­‰ï¼‰</li><li>NIAGADSï¼ˆå¦‚ Knight-ADRC EPIC æ•°æ®ï¼‰</li></ul></li><li><strong>æ–‡ä»¶ç±»å‹</strong>ï¼š<ul><li><code>.idat</code>ï¼ˆç”¨äºé‡å¤´åˆ†æï¼‰</li><li><code>.csv</code>ï¼ˆæ ‡å‡†åŒ– beta çŸ©é˜µï¼‰</li><li>phenotype ä¿¡æ¯ï¼ˆåŒ…å«è¯Šæ–­çŠ¶æ€ã€å¹´é¾„ã€æ€§åˆ«ã€è„‘åŒºã€RINã€PMIï¼‰</li></ul></li></ul><hr><h2 id="ğŸ”¹-Step-2-æ•°æ®é¢„å¤„ç†ä¸è´¨æ§ï¼ˆQCï¼‰"><a href="#ğŸ”¹-Step-2-æ•°æ®é¢„å¤„ç†ä¸è´¨æ§ï¼ˆQCï¼‰" class="headerlink" title="ğŸ”¹ Step 2. æ•°æ®é¢„å¤„ç†ä¸è´¨æ§ï¼ˆQCï¼‰"></a>ğŸ”¹ Step 2. æ•°æ®é¢„å¤„ç†ä¸è´¨æ§ï¼ˆQCï¼‰</h2><ul><li><strong>ç›®æ ‡</strong>ï¼šæ¸…æ´—æ•°æ®ï¼Œç¡®ä¿ç”²åŸºåŒ–ä¿¡å·çœŸå®ã€æ— æ‰¹æ¬¡åå·®ã€‚</li><li><strong>æµç¨‹</strong>ï¼š<ol><li>ç”¨ <code>minfi</code> æˆ– <code>ChAMP</code> è¯»å…¥ <code>.idat</code> æ–‡ä»¶ï¼›</li><li>æ‰§è¡Œ Noob &#x2F; Functional Normalizationï¼›</li><li>åˆ é™¤ï¼š<ul><li>æ¢é’ˆæ£€æµ‹ p å€¼ &gt; 0.01ï¼›</li><li>æ€§æŸ“è‰²ä½“æ¢é’ˆï¼ˆå¦‚éç›®æ ‡ï¼‰ï¼›</li><li>äº¤å‰ååº”æ¢é’ˆï¼›</li><li>å« SNP çš„æ¢é’ˆï¼›</li></ul></li><li>ä½¿ç”¨ <code>ComBat</code> æˆ– <code>removeBatchEffect</code> è¿›è¡Œæ‰¹æ¬¡æ ¡æ­£ï¼›</li><li>å¯ä¼°ç®—ç»†èƒç»„æˆï¼ˆ<code>estimateCellCounts()</code> æˆ– <code>EpiDISH</code>ï¼‰ç”¨äºåç»­å»ºæ¨¡æ§åˆ¶ã€‚</li></ol></li></ul><hr><h2 id="ğŸ”¹-Step-3-DMP-DMR-åˆ†æ"><a href="#ğŸ”¹-Step-3-DMP-DMR-åˆ†æ" class="headerlink" title="ğŸ”¹ Step 3. DMP &#x2F; DMR åˆ†æ"></a>ğŸ”¹ Step 3. DMP &#x2F; DMR åˆ†æ</h2><ul><li><strong>ç›®æ ‡</strong>ï¼šæ‰¾å‡º AD å’Œæ­£å¸¸äººä¹‹é—´å­˜åœ¨æ˜¾è‘—å·®å¼‚ç”²åŸºåŒ–çš„ä½ç‚¹å’ŒåŒºåŸŸã€‚</li><li><strong>æ–¹æ³•</strong>ï¼š<ul><li><code>limma</code>: ç”¨äº DMP åˆ†æ</li><li><code>DMRcate</code> &#x2F; <code>bumphunter</code>: ç”¨äºè¯†åˆ« DMRï¼ˆåŒºåŸŸæ€§ç”²åŸºåŒ–æ”¹å˜ï¼‰</li></ul></li><li><strong>è¾“å‡º</strong>ï¼š<ul><li>CpG IDã€Î”Î² å€¼ã€adj. p-value</li><li>DMR èµ·æ­¢ä½ç½®ã€åŒ…å« CpG æ•°ã€åŒºåŸŸæ³¨é‡Š</li></ul></li></ul><hr><h2 id="ğŸ”¹-Step-4-DMR-æ³¨é‡Šä¸å¯Œé›†åˆ†æ"><a href="#ğŸ”¹-Step-4-DMR-æ³¨é‡Šä¸å¯Œé›†åˆ†æ" class="headerlink" title="ğŸ”¹ Step 4. DMR æ³¨é‡Šä¸å¯Œé›†åˆ†æ"></a>ğŸ”¹ Step 4. DMR æ³¨é‡Šä¸å¯Œé›†åˆ†æ</h2><ul><li><strong>ç›®æ ‡</strong>ï¼šå°†å·®å¼‚ç”²åŸºåŒ–åŒºåŸŸæ³¨é‡Šåˆ°åŠŸèƒ½åŸºå› å¹¶è§£æå…¶ç”Ÿç‰©æ„ä¹‰ã€‚</li><li><strong>æ–¹æ³•</strong>ï¼š<ul><li>ä½¿ç”¨ <code>annotatr</code> æˆ– <code>Illumina EPIC æ³¨é‡ŠåŒ…</code> æ³¨é‡Š DMR åˆ°åŸºå› å¯åŠ¨å­&#x2F;ä½“åŒºï¼›</li><li>ç”¨ <code>missMethyl::gometh()</code> æˆ– <code>clusterProfiler</code> è¿›è¡Œ GO &#x2F; KEGG åˆ†æï¼›</li></ul></li><li><strong>ç»“æœ</strong>ï¼š<ul><li>ä¸ç¥ç»åŠŸèƒ½ã€ç‚ç—‡ã€ç»†èƒéª¨æ¶ç­‰ç›¸å…³çš„å¯Œé›†æ¡ç›®ï¼›</li><li>é‡ç‚¹é€šè·¯å¦‚ amyloid-beta clearanceã€tau phosphorylationã€synaptic signalingã€‚</li></ul></li></ul><hr><h2 id="ğŸ”¹-Step-5-å¤šç»„å­¦æ•´åˆåˆ†æï¼ˆMulti-omics-Integrationï¼‰"><a href="#ğŸ”¹-Step-5-å¤šç»„å­¦æ•´åˆåˆ†æï¼ˆMulti-omics-Integrationï¼‰" class="headerlink" title="ğŸ”¹ Step 5. å¤šç»„å­¦æ•´åˆåˆ†æï¼ˆMulti-omics Integrationï¼‰"></a>ğŸ”¹ Step 5. å¤šç»„å­¦æ•´åˆåˆ†æï¼ˆMulti-omics Integrationï¼‰</h2><p>è¿™æ˜¯æœ¬æµç¨‹çš„æ ¸å¿ƒæ‹“å±•éƒ¨åˆ†ï¼Œå…·ä½“å¦‚ä¸‹ï¼š</p><hr><h3 id="ğŸ”¸-5-1-DNAç”²åŸºåŒ–-Ã—-åŸºå› è¡¨è¾¾ï¼ˆæ•´åˆåˆ†æï¼‰"><a href="#ğŸ”¸-5-1-DNAç”²åŸºåŒ–-Ã—-åŸºå› è¡¨è¾¾ï¼ˆæ•´åˆåˆ†æï¼‰" class="headerlink" title="ğŸ”¸ 5.1 DNAç”²åŸºåŒ– Ã— åŸºå› è¡¨è¾¾ï¼ˆæ•´åˆåˆ†æï¼‰"></a>ğŸ”¸ 5.1 DNAç”²åŸºåŒ– Ã— åŸºå› è¡¨è¾¾ï¼ˆæ•´åˆåˆ†æï¼‰</h3><ul><li><p><strong>ç›®æ ‡</strong>ï¼šæ¢ç´¢ DMR æ˜¯å¦å½±å“å…¶é™„è¿‘åŸºå› çš„è¡¨è¾¾ï¼Œå‘ç°æ½œåœ¨è°ƒæ§æœºåˆ¶ã€‚</p></li><li><p><strong>è¾“å…¥</strong>ï¼š</p><ul><li>åŒä¸€æ‰¹æ¬¡æ ·æœ¬æˆ–é…å¯¹æ•°æ®çš„ RNA-seq è¡¨è¾¾çŸ©é˜µï¼›</li><li>DMR æ³¨é‡Šåˆ°åŸºå› åˆ—è¡¨ï¼›</li></ul></li><li><p><strong>æ–¹æ³•</strong>ï¼š</p><ul><li><p><strong>ç›´æ¥ç›¸å…³æ€§åˆ†æ</strong>ï¼š</p><figure class="highlight r"><table><tr><td class="gutter"><pre><span class="line">1</span><br></pre></td><td class="code"><pre><code class="hljs r">cor<span class="hljs-punctuation">(</span>beta<span class="hljs-punctuation">[</span>dmr_cpgs<span class="hljs-punctuation">,</span> <span class="hljs-punctuation">]</span><span class="hljs-punctuation">,</span> expression_matrix<span class="hljs-punctuation">[</span>annotated_genes<span class="hljs-punctuation">,</span> <span class="hljs-punctuation">]</span><span class="hljs-punctuation">)</span><br></code></pre></td></tr></table></figure></li><li><p><strong>å·®å¼‚è¡¨è¾¾æ•´åˆ</strong>ï¼š<br> ä½¿ç”¨ DESeq2&#x2F;edgeR é‰´å®š DEGï¼Œå¹¶ä¸ DMR-overlapped genes å–äº¤é›†ï¼›</p></li><li><p><strong>å…±è¡¨è¾¾ç½‘ç»œæ•´åˆ</strong>ï¼š<br> ä½¿ç”¨ <code>WGCNA</code> æ¨¡å—å…±å»ºç½‘ç»œï¼Œè§‚å¯Ÿæ¨¡å—ä¸­ DMR åŸºå› å¯Œé›†æƒ…å†µï¼›</p></li></ul></li><li><p><strong>äº§å‡º</strong>ï¼š</p><ul><li>ä¸€æ‰¹è¡¨è¾¾å—ç”²åŸºåŒ–è°ƒæ§çš„å€™é€‰è°ƒæ§åŸºå› ï¼›</li><li>å¯ä»¥æ„å»ºâ€œDMR â†’ DEGâ€è·¯å¾„å›¾ï¼Œå»ºè®®ç”¨ Cytoscape å±•ç¤ºã€‚</li></ul></li></ul><hr><h3 id="ğŸ”¸-5-2-DNAç”²åŸºåŒ–-Ã—-GWASï¼ˆmeQTL-åˆ†æï¼‰"><a href="#ğŸ”¸-5-2-DNAç”²åŸºåŒ–-Ã—-GWASï¼ˆmeQTL-åˆ†æï¼‰" class="headerlink" title="ğŸ”¸ 5.2 DNAç”²åŸºåŒ– Ã— GWASï¼ˆmeQTL åˆ†æï¼‰"></a>ğŸ”¸ 5.2 DNAç”²åŸºåŒ– Ã— GWASï¼ˆmeQTL åˆ†æï¼‰</h3><ul><li><p><strong>ç›®æ ‡</strong>ï¼šæ¢æµ‹ GWAS é£é™©ä½ç‚¹æ˜¯å¦é€šè¿‡è°ƒæ§ CpG ä½ç‚¹ç”²åŸºåŒ–æ°´å¹³å‚ä¸ AD æœºåˆ¶ã€‚</p></li><li><p><strong>è¾“å…¥</strong>ï¼š</p><ul><li>AD ç›¸å…³ GWAS summary statisticsï¼ˆå¦‚ IGAP, ADNIï¼‰ï¼›</li><li>CpG Î²å€¼çŸ©é˜µï¼›</li></ul></li><li><p><strong>æ–¹æ³•</strong>ï¼š</p><ul><li><p>æ„å»º cis-meQTL åˆ†ææ¨¡å‹ï¼š</p><figure class="highlight r"><table><tr><td class="gutter"><pre><span class="line">1</span><br></pre></td><td class="code"><pre><code class="hljs r">model <span class="hljs-operator">&lt;-</span> lm<span class="hljs-punctuation">(</span>beta_cpg <span class="hljs-operator">~</span> genotype_snp <span class="hljs-operator">+</span> covariates<span class="hljs-punctuation">)</span><br></code></pre></td></tr></table></figure></li><li><p>æ¨èå·¥å…·ï¼š<code>MatrixEQTL</code>, <code>FastQTL</code></p></li></ul></li><li><p><strong>è¾“å‡º</strong>ï¼š</p><ul><li>SNPâ€“CpG å¯¹ï¼›</li><li>å¯è§†åŒ– meQTL çƒ­å›¾æˆ– LocusZoom é£æ ¼å›¾è¡¨ï¼›</li><li>æ ‡è®°å‡ºâ€œGWASé£é™©ä½ç‚¹ â†’ ç”²åŸºåŒ–æ”¹å˜ â†’ è¡¨è¾¾æ”¹å˜â€çš„ä¸‰çº§æœºåˆ¶ã€‚</li></ul></li></ul><hr><h3 id="ğŸ”¸-5-3-DNAç”²åŸºåŒ–-Ã—-è›‹ç™½è´¨ç»„ï¼ˆå¦‚æœ‰ï¼‰"><a href="#ğŸ”¸-5-3-DNAç”²åŸºåŒ–-Ã—-è›‹ç™½è´¨ç»„ï¼ˆå¦‚æœ‰ï¼‰" class="headerlink" title="ğŸ”¸ 5.3 DNAç”²åŸºåŒ– Ã— è›‹ç™½è´¨ç»„ï¼ˆå¦‚æœ‰ï¼‰"></a>ğŸ”¸ 5.3 DNAç”²åŸºåŒ– Ã— è›‹ç™½è´¨ç»„ï¼ˆå¦‚æœ‰ï¼‰</h3><ul><li><strong>ç›®æ ‡</strong>ï¼šåˆ¤æ–­ DMR æ˜¯å¦æœ€ç»ˆå½±å“è›‹ç™½è¡¨è¾¾å±‚ã€‚</li><li><strong>æ–¹æ³•</strong>ï¼š<ul><li>æ„å»º CpGâ€“Geneâ€“Protein ä¸‰å±‚æ˜ å°„ç½‘ç»œï¼›</li><li>ä½¿ç”¨ <code>mixOmics::DIABLO</code> è¿›è¡Œå¤šç»„å­¦ block-wise æ¨¡å‹æ•´åˆï¼›</li></ul></li><li><strong>ç»“æœ</strong>ï¼š<ul><li>å¤šç»„å­¦ signatureï¼›</li><li>å¯ç”¨äºç”Ÿç‰©æ ‡å¿—ç‰©ç­›é€‰æˆ–äºšå‹è¯†åˆ«ã€‚</li></ul></li></ul><hr><h2 id="ğŸ”¹-Step-6-ç½‘ç»œæ„å»ºä¸å…³é”®å› å­è¯†åˆ«"><a href="#ğŸ”¹-Step-6-ç½‘ç»œæ„å»ºä¸å…³é”®å› å­è¯†åˆ«" class="headerlink" title="ğŸ”¹ Step 6. ç½‘ç»œæ„å»ºä¸å…³é”®å› å­è¯†åˆ«"></a>ğŸ”¹ Step 6. ç½‘ç»œæ„å»ºä¸å…³é”®å› å­è¯†åˆ«</h2><ul><li><strong>ç›®æ ‡</strong>ï¼šå°†å…³é”® CpGã€åŸºå› ã€è›‹ç™½ç»„ç»‡æˆè°ƒæ§ç½‘ç»œï¼Œç­›é€‰é‡è¦èŠ‚ç‚¹ï¼ˆhub genesï¼‰ã€‚</li><li><strong>å·¥å…·</strong>ï¼š<ul><li><code>Cytoscape</code>ï¼šå¯è§†åŒ–</li><li><code>igraph</code> &#x2F; <code>STRING</code>ï¼šç½‘ç»œæ‹“æ‰‘æŒ‡æ ‡åˆ†æï¼ˆdegree, betweennessï¼‰</li></ul></li><li><strong>è¡¥å……</strong>ï¼šä¹Ÿå¯ç»“åˆ <code>OmicsNet</code> å¹³å°å¿«é€Ÿç»˜å›¾</li></ul><hr><h2 id="ğŸ”¹-Step-7-ç”Ÿç‰©å­¦è§£é‡Šä¸éªŒè¯å»ºè®®"><a href="#ğŸ”¹-Step-7-ç”Ÿç‰©å­¦è§£é‡Šä¸éªŒè¯å»ºè®®" class="headerlink" title="ğŸ”¹ Step 7. ç”Ÿç‰©å­¦è§£é‡Šä¸éªŒè¯å»ºè®®"></a>ğŸ”¹ Step 7. ç”Ÿç‰©å­¦è§£é‡Šä¸éªŒè¯å»ºè®®</h2><ul><li>ç»“åˆç°æœ‰æ–‡çŒ®ç¡®è®¤å…³é”® CpG æ‰€åœ¨åŸºå› æ˜¯å¦å·²ä¸ AD ç›¸å…³ï¼›</li><li>è‹¥ä¸ºæ–°åŸºå› ï¼Œå¯è®¾è®¡å®éªŒéªŒè¯ï¼ˆqPCRã€bisulfite PCRï¼‰ï¼›</li><li>å¼ºè°ƒ top CpG æˆ– DMR çš„è°ƒæ§æœºåˆ¶ã€è„‘åŒºç‰¹å¼‚æ€§å’Œæ½œåœ¨é¶å‘æ€§ã€‚</li></ul><hr><h2 id="âœ…-æ€»ç»“å›¾ç¤ºå»ºè®®"><a href="#âœ…-æ€»ç»“å›¾ç¤ºå»ºè®®" class="headerlink" title="âœ… æ€»ç»“å›¾ç¤ºå»ºè®®"></a>âœ… æ€»ç»“å›¾ç¤ºå»ºè®®</h2><p>ä½ å¯ä»¥å°†ä»¥ä¸Šæµç¨‹ç»˜åˆ¶æˆæµç¨‹å›¾æˆ–ç½‘ç»œå›¾ï¼Œä¾‹å¦‚ä½¿ç”¨ä»¥ä¸‹æ¨¡å—ï¼š</p><figure class="highlight"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br><span class="line">4</span><br><span class="line">5</span><br></pre></td><td class="code"><pre><code class="hljs">ç”²åŸºåŒ–é¢„å¤„ç† â†’ DMP/DMRåˆ†æ â†’ æ³¨é‡Š â†’ å¯Œé›†åˆ†æ<br>       â†“                      â†“<br>   è¡¨è¾¾æ•´åˆåˆ†æ â†â€”â€”â€”â†’ GWASæ•´åˆï¼ˆmeQTLï¼‰<br>       â†“                      â†“<br>         å¤šç»„å­¦è”åˆç½‘ç»œ â†’ åŠŸèƒ½éªŒè¯ä¸ç»“æœå‘è¡¨<br></code></pre></td></tr></table></figure><p>å¯¹äºEWAS åˆ†æ</p><p>åœ¨è¡¨æ ¼ä¸‹æ–¹ç‚¹å‡» <strong>Download</strong> å¯ä»¥å°†æœç´¢ç»“æœå¯¼å‡º CSV æ–‡ä»¶ï¼Œæ–¹ä¾¿ä½ ï¼š</p><ul><li>ä¸ä½ è‡ªå·±çš„ EWAS ç»“æœäº¤å‰éªŒè¯ï¼›</li><li>è®­ç»ƒé¢„æµ‹æ¨¡å‹ï¼›</li><li>æ£€æŸ¥å“ªäº› CpG æ˜¯ novel çš„ï¼ˆæœªè¢«å‘ç°è¿‡çš„ï¼‰ã€‚</li></ul>]]></content>
    
    
    <categories>
      
      <category>research</category>
      
    </categories>
    
    
    <tags>
      
      <tag>research</tag>
      
    </tags>
    
  </entry>
  
  
  
  <entry>
    <title>paper-interpretation-6</title>
    <link href="/2025/06/24/paper-interpretation-6/"/>
    <url>/2025/06/24/paper-interpretation-6/</url>
    
    <content type="html"><![CDATA[<p>This paperâ€™s interpretation is about a quite new area developed recently, about the role of Artificial Intelligence (which is AI) in genetic testing. AI started from ChatGPT has brought the attention of billions of people around the world, even though someone claims that academic misconduct will increase due to the presence of a large language model (LLM), artificial intelligence is significantly beneficial in the areas ranging from computer science to biology statistics. </p><p>In the paper Comprehensive Genome Analysis and Variant Detection at Scale using DRAGEN, the researchers investigate the ability of the AI model DRAGEN developed specifically for genome analysis. They test the ability of DRAGEN to analyze, compare, and report the genome analysis to investigate the potential of AI in the genetic testing area and also in another area in biology as well. Therefore, this paper is really valuable in combining AI with genetic testing, pointing a new direction for future research.</p><img src="/2025/06/24/paper-interpretation-6/workflow1.png" class="" title="image here"><img src="/2025/06/24/paper-interpretation-6/workflow2.png" class="" title="image here"><p>**Research background<br>** The model DRAGEN developed by a team has demonstrated a strong ability to detect the different variants of the gene and map it with pangenome references. The researchers reported that the DRAGEN has outperformed the current state-of-art gene testing method employed by humans using its high accuracy and speed to increase efficiency and lower the cost. Therefore, the researchers want to determine the capabilities of DRAGEN through several comparisons with traditional gene testing methods.</p><p><strong>Experiment Object</strong></p><p>DRAGEN belongs to the genome analysis phase during gene testing. As the current whole genome sequencing (WGS) method for determining the DNA testing will generate large amount of data and be time consuming using traditional method to handle and analysis these data, the researchers want to compare the DRAGE with traditional method on accuracy, efficiency and credibility to provide a more efficient way for other researchers.</p><p><strong>Experiment Result</strong></p><ol><li><p>The researchers first determine that the algorithm is in great scale and accuracy when treating comprehensive genomics. The researchers demonstrate that the DRAGEN has the capability to capture the entire range from single variants to larger variations across the entire genome at scale and reports them in standardized VCF files even though genes that are highly similar were employed during testing. Also, the DRAGEN is also able to resolve the complete variant spectrum at scale and accuracy. For insertions, which are often the hardest for SV callers7, DRAGEN achieved an F-measure of 76.90%, which more than doubled the performance of Manta (34.90%) and Delly (4.70%; Lumpy did not report any insertions). Similarly, DRAGEN achieved a better F-measure (82.60%) for deletions (50+ bp) than Manta (70.80%), Delly (68.30%) and Lumpy (66.80%).</p><img src="/2025/06/24/paper-interpretation-6/box.png" class="" title="image here"></li><li><p>At the same time, when treating with the population size comprehensive variant testing, the DRAGEN also demonstrates higher accuracy than other models currently employed by people. For small variants (&lt;50 bp), the DRAGEN Iterative gVCF Genotyper can efficiently aggregate hundreds of thousands to millions of gVCFs to perform joint calling and genotyping. Before aggregation, variants with DRAGEN machine learning quality scores below a threshold of QUAL &#x3D; 3 were filtered. The joint call had an average per-sample SNV recall of 99.92%, a precision of 99.78% F1 measure of 99.85% indel recall of 99.84%, a precision of 99.71%, an F1 measure of 99.77%, an evaluated based on GIAB samples.</p><img src="/2025/06/24/paper-interpretation-6/column.png" class="" title="image here"></li><li><p>For the population level indel and SNV variation detection, DRAGEN is also in significant precision. For indels, DRA- GEN generated 7,140,867 singleton, 8,237,880 rare, and 4,229,692 common indels, whereas the GATK call had 56.18% fewer singleton (3,129,240), 30.48% fewer rare (5,727,021) and 4.88% fewer common indel variants (4,023,422). Specifically, among SNVs with functional impact, DRAGEN called 706,355 missense SNVs (33.13% rare and 1.75% novel), 438,735 synonymous SNVs (36.59% rare and 1.18% novel), and 195,345 SNVs with other higher functional impact, including stop&#x2F;startâ€“gain&#x2F;loss and splice mutations (33.35% rare and 3.17% novel).</p></li></ol><img src="/2025/06/24/paper-interpretation-6/colorful.png" class="" title="image here"> <p><strong>Impact and Importance</strong></p><p>The creation and deployment of the DRAGEN (Dynamic Read Analysis for GENomics) platform for scaled variant calling and whole-genome analysis is a major advancement for research investigations and clinical diagnostics. DRAGEN utilizes hardware-accelerated algorithms to dramatically reduce the time and computational cost of sequencing data analysis, enabling high-speed and precise identification of genetic variants in massive datasets.</p><p>The platform is particularly relevant in the context of large-scale genomics research studies and precision medicine initiatives, where high-throughput and precise variant calling is essential. Through optimizing the speed and precision of genome alignment, variant detection, and genotyping, DRAGEN allows researchers and clinicians to analyze thousands of genomes rapidlyâ€”enabling rapid detection of genetic disease, cancer mutations, and population-scale genetic variation.</p><p>Furthermore, DRAGENâ€™s cloud-based scalability and portability ensure the tool can be highly adaptable to research environments, from university labs to national healthcare programs. Its ability to precisely detect common and uncommon variants enhances diagnostic assurance, especially within the clinical environment where genetic discoveries may have direct impacts on treatment decisions. Together, DRAGEN accelerates the path from sequencing to actionable insights, bringing us closer towards the ultimate destination of genomic information being more useful and more readily available to research and individualized medicine. </p><p><strong>[1]</strong></p><ol><li>Behera, S.; Catreux, S.; Rossi, M.; Truong, S.; Huang, Z.; Ruehle, M.; Visvanath, A.; Parnaby, G.; Roddey, C.; Onuchic, V.; et al. Comprehensive genome analysis and variant detection at scale using DRAGEN. <em>Nat Biotechnol</em> <strong>2024</strong>, doi:10.1038&#x2F;s41587-024-02382-1.</li></ol>]]></content>
    
    
    <categories>
      
      <category>paper_interpretation</category>
      
    </categories>
    
    
    <tags>
      
      <tag>biology</tag>
      
    </tags>
    
  </entry>
  
  
  
  <entry>
    <title>usabo-2023</title>
    <link href="/2025/06/24/usabo-2023/"/>
    <url>/2025/06/24/usabo-2023/</url>
    
    <content type="html"><![CDATA[<p>This is the analysis for USABO 2023 open round</p><p>USABO2023éš¾åº¦ç›¸å¯¹ç®€å•ï¼Œæ²¡æœ‰2022å’Œ2024é‚£ä¹ˆéš¾ï¼Œä½†æ˜¯ç›¸åº”çš„åˆ†æ•°çº¿å°±æ˜¯æ¯”è¾ƒé«˜ï¼Œæ‹¿é‡‘å¥–ä¾ç„¶å¾ˆä¸å®¹æ˜“</p><p>è¿˜æ˜¯æœ‰ä¸å°‘ç»†èŠ‚éœ€è¦æ³¨æ„</p><p>åºŸè¯ä¸å¤šè¯´ï¼Œç›´æ¥å¼€å§‹æ­£é¢˜</p><img src="/2025/06/24/usabo-2023/1.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br></pre></td><td class="code"><pre><code class="hljs bash">quesiton 1: D<br>binary fissionæ˜¯ç»†èŒç”¨çš„<br>asynthetic fission æ˜¯ä¸å¯¹ç§°çš„ï¼Œä¹Ÿä¸æ˜¯physical seperation of eukaryotic cell<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/2.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 2: Aï¼Œé€åˆ†é¢˜ï¼Œè€ƒå¯Ÿåˆ†å­çš„è¿åŠ¨<br>Aé€‰é¡¹æ­£ç¡®ï¼Œæ›´å¤šçš„ç¦»å­ä¼šæº¶è§£åœ¨æ°´ä¸­ï¼Œæ‰€ä»¥æ›´ä½çš„æ°´åŠ¿<br>BCDEå…¨éƒ¨æ’é™¤<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/3.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 3: D é€åˆ†é¢˜<br>lymphocytesæ˜¯é€‚åº”æ€§å…ç–«ï¼Œä¸æ˜¯innate<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/4.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 4ï¼š B èƒŒè¯µé¢˜ï¼Œè€ƒå¯Ÿç”Ÿç‰©æŠ€æœ¯æ–¹å‘<br>é€‰Dï¼Œè¿™ç§æœ€è€é«˜æ¸©<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/5.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 5ï¼šD èƒŒè¯µé¢˜ï¼Œè€ƒå¯Ÿç»†èƒå‘¼å¸ç›¸å…³åˆ†å­<br>lactateæ˜¯äº§ç‰©ï¼Œä¸æ˜¯final acceptor<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/6.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 6: A èƒŒè¯µé¢˜ï¼Œè€ƒå¯Ÿç»†èƒå‘¼å¸<br>ATPæ˜¯é€šè¿‡ GDPå’ŒGTPçš„è½¬åŒ–å½¢æˆï¼Œä¸æ˜¯ç›´æ¥å½¢æˆ<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/7.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 7: C é€åˆ†é¢˜<br>ç›´æ¥è§‚å¯Ÿå›¾ç‰‡å³å¯<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/8.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 8: A èƒŒè¯µé¢˜<br>chaperoninæ˜¯å¸®åŠ©è›‹ç™½è´¨æŠ˜å çš„ï¼Œå…¶ä»–çš„æ˜æ˜¾é”™è¯¯<br>Ubiquitinationæ˜¯æ³›ç´ åŒ–<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/9.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 9: C çº¯é€åˆ†é¢˜ï¼Œçœ‹å…ƒç´ å‘¨æœŸè¡¨å³å¯<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/10.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 10: B<br>ç›´æ¥çœ‹å›¾å¯å¾—ï¼Œdouble bondä¼šå¯¼è‡´é“¾æ‰­æ›²ä»¥åŠä¸é¥±å’Œ<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/11.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br><span class="line">4</span><br><span class="line">5</span><br><span class="line">6</span><br><span class="line">7</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 11: C æ¤ç‰©èŠ±ç²‰ä¼ æ’­é€”å¾„<br>åŠ¨ç‰©ä¼ æ’­é€šå¸¸ä¾èµ–èŠ±èœœçš„å­˜åœ¨æˆ–è€…æ˜¯èŠ±çš„å¤§å°æ¯”è¾ƒå¤§<br>Cé€‰é¡¹æ˜¯å†œä½œç‰©ï¼Œä¸€èˆ¬é€šè¿‡é£æ¥ä¼ æ’­ï¼Œsugar caneçš„è¯å¾ˆå°ï¼Œå¸å¼•ä¸åˆ°æ˜†è™«<br>Aé€‰é¡¹æ˜¯ä¸‰å¶è‰ï¼Œé€šè¿‡æ˜†è™«ä¼ æ’­ï¼Œä¸»è¦æ˜¯å± å¥‰<br>Bé€‰é¡¹æ˜¯æ— èŠ±æœï¼Œé€šè¿‡æ˜†è™«ä¼ æ’­<br>Dé€‰é¡¹é€šè¿‡è‹è‡ä¼ æ’­<br>Eé€‰é¡¹æ˜¯é¾™èˆŒå…°ï¼Œä¾èµ–è™è ä¼ ç²‰<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/12.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 12: C è€ƒå¯Ÿæ¤ç‰©ç»“æ„<br>æ˜æ˜¾é€‰Cï¼Œæ ¹éƒ¨è¦æ˜¯æœ‰æ²¹è†œçš„è¯ï¼Œæ¤ç‰©ä¼šæ­»çš„ï¼Œæ— æ³•å‘¼å¸<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/13.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 13: E è€ƒå¯Ÿæ¤ç‰©ç»†èƒ<br>companion cellæ˜¯ç»™phloemæä¾›èƒ½é‡ï¼ŒåŒæ—¶ç­›é€‰è¿›å…¥ç‰©<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/14.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 14: C è€ƒå¯Ÿæ¤ç‰©å—ç²¾è¿‡ç¨‹<br>ä¸€å®šæ˜¯å…ˆåˆ°stigmaï¼Œç„¶ååœ¨è¿‡style<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/15.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 15: A è€ƒå¯Ÿæ¤ç‰©çš„è¿è¾“ç³»ç»Ÿ<br>pressure-flow hypothesisæ˜¯æŒ‡phloemè¿è¾“ä»¥æ¥æ°´å‹çš„é«˜ä½ä¸åŒï¼Œè€Œä¸æ˜¯æ°´åŠ¿çš„æ¢¯åº¦<br>æ‰€ä»¥<span class="hljs-built_in">source</span>çš„ä½æ°´åŠ¿è®©å¤§é‡æ°´è¿›å…¥<span class="hljs-built_in">source</span>ï¼Œä»è€Œé€ æˆé«˜æ°´å‹<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/16.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 16: C è€ƒå¯Ÿç‰¹æ®ŠåŠ¨ç‰©è¡Œä¸º<br>Elysiaæ˜¯ä¸€ç§åƒæµ·è›è“ï¼Œä»–ä»¬è¿›é£Ÿæµ·è—»ï¼Œç„¶åæå–é‡Œé¢çš„å¶ç»¿ç´ ç”¨äºå…‰åˆä½œç”¨<br>æ‰€ä»¥æ˜¯Kleptoplastyï¼Œç›—é£Ÿè´¨ä½“<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/17.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 17:D è€ƒå¯Ÿæ¤ç‰©ç»“æ„<br>Casparian strip çš„ä½œç”¨æ˜¯å¼ºè¿«è°ä»symplast pathwayè¿›å…¥ï¼Œæ‰€ä»¥Dé€‰é¡¹æ­£ç¡®ï¼Œsymplast pathwayçš„ç‰¹ç‚¹å°±æ˜¯å¼ºè¿«æ°´è¿›å…¥ç»†èƒ<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/18.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 18: C <br>å¢åŠ çŸ¿ç‰©ç¦»å­å¯ä»¥å¢åŠ è¯´åˆ†å­ä¹‹é—´çš„cohesio å’Œadhesion<br>ABDEå…¨éƒ½æ˜¯é”™çš„<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/19.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 19: B è€ƒå¯Ÿè‚Œè‚‰æ”¶ç¼©ï¼ŒèƒŒè¯µé€åˆ†é¢˜<br>filament slidingä¸“æœ‰åè¯<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/question.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br></pre></td><td class="code"><pre><code class="hljs bash">USABOå°‘è§çš„å¤šé¢˜å¥—åœ¨ä¸€èµ·çš„é¢˜ï¼Œéš¾åº¦ä¸å¤§ï¼Œä½†æ˜¯è¦æŠŠæ§å¥½è¯»é¢˜æ—¶é—´<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/20.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 20: A è€ƒå¯Ÿcardiac cycle<br>èƒ½çœ‹å‡ºæœ‰å‹åŠ›æ—¶æ‰æœ‰è¡€æ¶²æµåŠ¨ï¼Œæ‰€ä»¥æ˜¯A<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/21.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 21: A è¯»é¢˜å³å¯<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/22.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 22: D è¯»é¢˜å³å¯<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/23.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 23: C negativeæ˜¯ç¦»å¼€ï¼Œé‚£positiveå°±æ˜¯æ¥è¿‘<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/24.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 24: B çœ‹è¡¨å³å¯ï¼Œåœ¨å‹åŠ›ä½çš„åœ°æ–¹ä¼šæœ‰positive<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/25.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 25: E antibodyéƒ½æœ‰ä¸¤ä¸ªbinding siteï¼Œè€ƒå¯Ÿäººä½“å…ç–«å­¦<br>é™¤äº†ç‰¹æ®Šçš„ç»†èƒè¡¨é¢ç»“åˆä½“ï¼Œæ¯”å¦‚è¯´T-cellä¸Šé¢çš„é‚£ä¸ª<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/26.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br><span class="line">4</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 26: C è€ƒå¯Ÿç”Ÿç‰©countercurrent çš„ä¾‹å­<br>countercurrentéœ€è¦è‡³å°‘ä¸¤è‚¡ä¸åŒæµå‘çš„è¡€æ¶²<br>é±¼ç±»çš„æ°”ä½“äº¤æ¢å’Œä¼é¹…çš„è„šæŒéƒ½æ˜¯å…¸å‹çš„countercurrentçš„ä¾‹å­<br>äººç±»ä¸ä¼šä¾èµ–äºè¿™ä¸€æ–¹æ³•<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/27.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br><span class="line">4</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 27: C è¿™é“é¢˜æ¯”è¾ƒç”Ÿåƒ»ï¼Œè€ƒå¯Ÿéº»é†‰è¯çš„ä¸åŒåŠŸæ•ˆï¼Œæœ¬è´¨ä¸Šæ˜¯è€ƒå¯Ÿäººä½“æ¿€ç´ ä½œç”¨<br>Cé€‰é¡¹ä¸æ˜¯ç†ç”±çš„åŸå› æ˜¯ketamine hydrochlorideéš¾ä»¥é™è§£ï¼Œé†’è½¬è¿‡ç¨‹æ˜¯ä¸€ä¸ªé€æ­¥çš„è¿‡ç¨‹ï¼Œç—…äººä¼šé€æ¸é†’æ¥ï¼Œä¸ä¼šçªç„¶çå¼€çœ¼ç›æ¸…é†’ï¼Œæ‰€ä»¥é”™è¯¯<br><br>è¿™ç§é¢˜å»ºè®®ç®€å•æ€è€ƒè¿‡åå¦‚æœä¸ä¼šåšå°±æ”¾å¼ƒæˆ–è€…éšä¾¿è’™ä¸€ä¸ªï¼Œå…¶ä»–äººå¤§æ¦‚ç‡ä¹Ÿåšä¸å‡ºæ¥ï¼Œä¸è¦åœ¨è¿™ä¸ªä¸Šé¢æµªè´¹æ—¶é—´<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/28.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 28: B è€ƒå¯Ÿäººä½“è¥å…»å­¦ï¼Œç›´æ¥èƒŒè¯µcampbellé‡Œçš„é‚£ä¸ªè¡¨å°±å¯ä»¥äº†<br>niacinæ˜¯ç»´ç”Ÿç´ B3çš„æˆåˆ†,æœ‰é¢„é˜²ç³™çš®ç—…çš„ä½œç”¨<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/vitamin.png" class="" title="image here"><img src="/2025/06/24/usabo-2023/29.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 29: C è€ƒå¯Ÿäººä½“çœ¼ç›ç»“æ„ï¼Œé€åˆ†é¢˜<br>optic diské‚£é‡Œæ²¡æœ‰rod æˆ–è€… cone receptorï¼Œæ‰€ä»¥æ˜¯ç›²ç‚¹<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/30.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 30: Cè€ƒå¯Ÿå®éªŒè®¾è®¡<br><span class="hljs-built_in">test</span> vitamine Dï¼Œæ‰€ä»¥salineæ˜¯control group<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/31.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 31: E è€ƒå¯Ÿç”Ÿç‰©è¡Œä¸º<br>fixed action patternæ˜¯å›ºå®šè¡Œä¸ºï¼Œæ­£ç¡®<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/32.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 32: C è€ƒå¯Ÿç”Ÿç‰©è¡Œä¸º<br>orientationï¼šæ˜¯è‡ªä¸»å¯¼èˆªï¼Œè‡ªå·±é€šè¿‡ç°æœ‰æ¡ä»¶åˆ°è¾¾ç›®çš„åœ°<br>navigationæ˜¯é€šè¿‡å…¶ä»–è‡ªç„¶ç•Œä¸­çš„æç¤ºå¯¼èˆªï¼ŒåŒ…æ‹¬äºº<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/33.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br><span class="line">4</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 33: D è€ƒå¯Ÿç”Ÿç‰©è¡Œä¸º<br>optimal foragingçš„å®šä¹‰ï¼Œå»ºè®®èƒŒè¯µ<br>ABCé€‰é¡¹æ˜æ˜¾é”™è¯¯ï¼Œ optimal foragingéœ€è¦è€ƒè™‘èƒ½é‡å’Œæ—¶é—´<br>Eé€‰é¡¹é”™è¯¯ï¼Œè¿™ä¸æ˜¯optimal foragingï¼Œè¿™å¯èƒ½æ˜¯kin selection<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/34.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 34: Eï¼Œè€ƒå¯Ÿç”Ÿç‰©æŠ€æœ¯ï¼ŒèƒŒè¯µé¢˜<br>é€‰Eï¼Œåªæœ‰microdeletionéœ€è¦FISHæ¢æµ‹<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/35.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 35: C è€ƒå¯ŸåŸºå› ç»“æ„<br>é¦–å…ˆæ˜¯unbalanced carrierï¼Œ ç„¶åæ˜¯q armè¢«å¤åˆ¶ï¼Œæ‰€ä»¥æ˜¯nonrandom X inactivation <br>è¢«å¤åˆ¶çš„é‚£ä¸ªæ›´å®¹æ˜“é­åˆ°æŠ‘åˆ¶<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/36.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 36: Cè€ƒå¯ŸåŸºå› ç¼–è¾‘<br>æ˜¯autosomal dominantç„¶åå„¿å­æ²¡æœ‰ç—‡çŠ¶çš„è¯ï¼Œè¯´æ˜ç”·äººæ˜¯aaï¼Œå¥³äººæ˜¯Aa<br>æ‰€ä»¥å¥³å„¿æ˜¯Aaçš„å¯èƒ½æ€§æ˜¯50%<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/37.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br><span class="line">4</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 37: Aè€ƒå¯Ÿé—ä¼ å­¦<br>é¦–å…ˆæ˜¯å„¿å­æœ‰klinefelterç—‡çŠ¶æ‰€ä»¥æ˜¯ä¸¤ä¸ªXä¸€ä¸ªYï¼Œç„¶åå¦ä¸€ä¸ªå„¿å­æ²¡æœ‰ç—‡çŠ¶æ—¶æ­£å¸¸çš„XY<br>æ‰€ä»¥å¤«å¦»ä¸¤ä¸ªå¿…é¡»æ¯äº²æœ‰ï¼Œç„¶åé—ä¼ äº†ä¸¤ä¸ªXï¼Œçˆ¶äº²æœ‰æˆ–è€…æ²¡æœ‰ä¸ä¼šäº§ç”Ÿå½±å“ï¼Œå› ä¸ºklinefelteråªæœ‰å¯èƒ½æ˜¯æ¯äº²é‚£è¾¹åˆ†è£‚é”™è¯¯<br>æ‰€ä»¥Iæ˜¯é”™è¯¯çš„ï¼Œæ¯äº²å¿…é¡»æœ‰<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/38.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 38: Cé€åˆ†é¢˜<br>å¥—å…¬å¼è®¡ç®—å°±å¯ä»¥äº†<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/39.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 39: Aè€ƒå¯ŸåŸºå› çªå˜<br>ä¸¤ä¸ªç›¸åŒçš„repeatå¾ˆæœ‰å¯èƒ½é€ æˆdeletionæˆ–è€…frameshiftå…¶ä»–çš„éƒ½å¤ªå¯èƒ½<br>è€ƒè™‘åˆ°è¿™ä¸ªç‰‡æ®µçŸ­çš„ç‰¹æ®Šæ€§ï¼ŒGTGGTGï¼Œè¿™ä¸ªframeshiftçš„æ¦‚ç‡æ¯”deletionè¦ä½ï¼Œæ‰€ä»¥é€‰A<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/40.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br><span class="line">4</span><br><span class="line">5</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 40: Dè€ƒå¯Ÿé—ä¼ å­¦ï¼Œé€åˆ†é¢˜<br>é¦–å…ˆæ˜¯dominantçš„ï¼Œç„¶åä¸¤ä¸ªæ‚åˆå­çš„å®¶é•¿æ˜¯Aaå­©å­æœ‰75%çš„æ¦‚ç‡æ˜¯æºå¸¦è€…<br>ç„¶åå¦‚æœæ˜¯æºå¸¦è€…çš„è¯ï¼Œ70%æœ‰ç™Œç—‡<br>å¦‚æœä¸æ˜¯æºå¸¦è€…4%æœ‰ç™Œç—‡<br>æ‰€ä»¥æ˜¯0.75*0.7+0.04*0.25=0.535<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/41.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 41: B è€ƒå¯Ÿç—…ç†å­¦<br>è¿™ä¸ªé¢˜å°±æ˜¯èƒŒè¯µé¢˜ï¼ŒèƒŒåˆ°äº†å°±ä¼šï¼Œæ²¡æœ‰èƒŒè¿™ä¹ˆåçš„çŸ¥è¯†ç‚¹å°±ä¸ä¼š<br>prader-willi syndromeæ˜¯è¢«unipqrental disomyäº§ç”Ÿçš„ï¼Œæœ‰å›¾ä¸­å¯ä»¥çœ‹åˆ°å­©å­å’Œçš„15å·æŸ“è‰²ä½“å’Œæ¯äº²å®Œå…¨ä¸€æ ·ï¼Œæ„å‘³ç€åœ¨meiosisé˜¶æ®µï¼Œæ¯äº²çš„ç¬¬15å·æŸ“è‰²ä½“æ²¡æœ‰å‘ç”Ÿåˆ†ç¦»ï¼Œå¯¼è‡´æ²¡æœ‰çˆ¶äº²çš„åŸºå› ï¼Œæ‰€ä»¥å¯¼è‡´prader-willi syndromåœ¨15å·æŸ“è‰²ä½“ä¸Šé¢<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/42.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br><span class="line">4</span><br><span class="line">5</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 42: B è€ƒå¯Ÿé—ä¼ å­¦<br>é¦–å…ˆæ˜¯autosomal recessive<br>å­©å­æ˜¯aaï¼Œæ‰€ä»¥femaleå®¶é•¿å¿…ç„¶æºå¸¦è‡´ç—…åŸºå› ï¼ŒAa æˆ–è€…aa<br>åœ¨å¾€ä¸Šæ¨ï¼Œå¦‚æœæ˜¯Aaçš„è¯ï¼Œgrandmotheræœ‰å¯èƒ½æ˜¯AAï¼ŒAaï¼Œaa å¦‚æœæ˜¯aaçš„è¯ï¼Œgrandmotheræœ‰å¯èƒ½æ˜¯aa æˆ–è€…Aa<br>åœ¨è€ƒè™‘é—ä¼ å¯èƒ½æ€§çš„è¯ï¼Œé€‰67%<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/43.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br><span class="line">4</span><br><span class="line">5</span><br><span class="line">6</span><br><span class="line">7</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 43: A è€ƒå¯Ÿecology<br>inbreeding depressionåœ¨å°ç§ç¾¤æ•°é‡é‡Œæ˜¯Allee effetçš„å…¸å‹ä»£è¡¨<br>Allee effectæ˜¯æŒ‡è¿‡åº¦ç¨€ç–æˆ–è€…ç¨ å¯†å•Šçš„ç§ç¾¤åˆ†å¸ƒä¼šé™ä½å‡ºç”Ÿç‡ã€‚<br>è¿‡å°ç§ç¾¤æ•°é‡ä¼šå¸¦æ¥äº¤é…æœºä¼šå‡å°‘<br>å‰©ä¸‹çš„BCDEé”™çš„æ¯”è¾ƒæ˜æ˜¾<br>dollo lawæ˜¯æŒ‡ç§ç¾¤éš¾ä»¥æ¢å¤ï¼Œä½†é¢˜ç›®ä¸­æ²¡æœ‰æåˆ°ç§ç¾¤è¢«ç ´å<br>ä¸­åº¦å¹²æ‰°å‡è¯´è·Ÿé¢˜ç›®å®Œå…¨æ²¡æœ‰å…³ç³»ï¼Œè¿™ä¸ªæ˜¯æµ‹é‡ç§ç¾¤ä¸°å¯Œåº¦çš„<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/44.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 44: A è€ƒå¯Ÿç”Ÿç‰©è¡Œä¸º<br>anhydrobiosisæ˜¯è„±æ°´ç”Ÿå­˜ï¼Œåƒæ°´ç†Šè™«ä¸€æ ·<br>æ‰€ä»¥Aæ˜æ˜¾é”™è¯¯ï¼ŒåŠ é€Ÿç»†èƒå¾ªç¯ä¼šåŠ å¿«è¡°è€ï¼Œé™ä½å¯¿å‘½ï¼Œæé«˜æ–°é™ˆä»£è°¢å¼ºåº¦<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/45.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 45: A è€ƒå¯Ÿç¯å¢ƒå­¦<br>CO2åœ¨å†¬å¤©æ¯”å¤å¤©å¤šæ˜¯å› ä¸ºï¼ŒåŒ—åŠçƒæœ‰æ›´å¤šçš„æ¤ç‰©ï¼Œå…‰åˆä½œç”¨è¿›å…¥å†¬å¤©é™ä½ï¼Œå¯¼è‡´äºŒæ°§åŒ–ç¢³å¢å¤š<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/46.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 46: Dè€ƒå¯Ÿecology<br>èƒ½æ˜æ˜¾çœ‹åˆ°æœ‰ç§ç¾¤å…±å­˜çš„ç°è±¡ï¼Œæ¯”æ–¹è¯´71 å’Œ 29 é‚£ç»„<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/47.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 47: Eè€ƒå¯Ÿecology<br>ä¸¤ä¸ªç»†èŒå…±ç”Ÿåœ¨å£è…”ä¸­ï¼Œåªæœ‰ä¸€ä¸ªèƒ½äº§ç”ŸèŒè†œï¼Œè¯´æ˜ä¸€ç§ç»†èŒå¯¹å¦å¤–ä¸€ç§æœ‰è´Ÿé¢æ•ˆæœ<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/48.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 48: Eç»å…¸ç”Ÿç‰©å­¦æµ‹é‡æ–¹æ³•<br>25*33/5=165<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/49.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 49: D DNA ä¿¡æ¯æ°¸è¿œæ˜¯æœ€å‡†ç¡®çš„åœ¨é—ä¼ å­¦ä¸­å¦‚æœè¦æµ‹å®šä¸¤ä¸ªç‰©ç§çš„å…³ç³»<br></code></pre></td></tr></table></figure><img src="/2025/06/24/usabo-2023/50.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 50: A è€ƒå¯Ÿç”Ÿç‰©è¿›åŒ–choanoflagellateçš„ä½œç”¨ä¸»è¦æ˜¯æœ‰ä¸€åœˆæ”¶ç¼©ç¯åœ¨ç”Ÿç‰©ä¸Šé¢<br>è€Œä¸æ˜¯çœ¼ç‚¹æˆ–è€…colonialç¾¤ä½“å…³ç³»<br></code></pre></td></tr></table></figure>]]></content>
    
    
    <categories>
      
      <category>usabo</category>
      
    </categories>
    
    
    <tags>
      
      <tag>competition</tag>
      
    </tags>
    
  </entry>
  
  
  
  <entry>
    <title>paper-interpretation-5</title>
    <link href="/2025/06/23/paper-interpretation-5/"/>
    <url>/2025/06/23/paper-interpretation-5/</url>
    
    <content type="html"><![CDATA[<p>This is the 5th paper interpretation for this blog, this paper interpretation is about a new topic, the epigenetic regulation in Alzheimerâ€™s disease which the researchers used the bioinformatics method to analyze the function and mechanism of epigenetic regulation, especially the DNA methylation in Alzheimerâ€™s disease. </p><p>The paper Cross-tissue analysis of blood and brain epigenome-wide association studies in Alzheimerâ€™s disease. The paper is about investigating the interaction between the blood and brain and then analyzing the differential methylation Regions (DMRs) present in the blood and brain to determine the effect of methylation on Alzheimerâ€™s disease.</p> <img src="/2025/06/23/paper-interpretation-5/mechanism5.png" class="" title="image here"><p><strong>Research Background</strong></p><p>Alzheimerâ€™s disease (AD) is one of the most common causes of dementia and affects about 11% of people that is 65 years old in the US. As the methylated DNA is relatively stable compared to normal DNA, it could serve as a suitable biomarker for AD disease. Also, as studies have pointed out differential DNA methylation could be detected 3 years before the onset of dementia, DNA methylation hence serves as a valuable direction for the clinical diagnosis and prevention of AD. To be noticed that, blood methylation detection provides a much easier way to detect Alzheimerâ€™s disease than other methods because getting blood samples from patients is relatively easy, and if the relationship between blood and brain methylation has been proven, blood testing for AD will be a promising new method.</p> <img src="/2025/06/23/paper-interpretation-5/filtering.png" class="" title="image here"><p><strong>Experiment Object</strong></p><p>In this study, the researchers want to determine both the mechanistic and biomarkers importance for AD. The researchers measured the two databases of Epigenome-wide associative studies (EWAS) conducted by the Alzheimerâ€™s Disease Neuroimaging Initiative (ADNI)14 and the Australian Imaging, Biomarkers, and Lifestyle (AIBL) recently to granted accurate results to investigate the blood and brain DNA methylation profile. To understand the function roles of methylation difference and the feasibility of methylation difference serving as biomarkers, several integrative analyses of methylations with genetic variants, gene expressions, and transcription factor binding sites have been conducted.</p><p><strong>Experiment Result</strong></p><ol><li><p>Meta-analysis of DMRs region in the blood and brain demonstrates that methylation difference is significantly associated with AD at individual CpGs and genomic regions in the blood. After adjusting for the accuracy, the inverse-variance fixed-effects meta-analysis model identified 5 CpGs, mapped to the SPIDR, CDH6 genes, and intergenic regions at a 5% false discovery rate (FDR). As the SPIDR gene coded for the scaffold protein and the CDH6 gene coded for the cadherin protein, high fidelity was achieved due to their regulation towards the recombinant structure. Using meta-analysis P-values for individual CpGs as input, comb-p software identified 9 differentially methylated regions (DMRs) at 5% Sidak P-value after multiple comparison corrections.  </p><img src="/2025/06/23/paper-interpretation-5/blood-brain.png" class="" title="image here"><img src="/2025/06/23/paper-interpretation-5/CpG.png" class="" title="image here"></li><li><p>After conducting a cross-tissue meta-analysis, researchers identified that AD-associated methylation difference will take place both in the brain and blood. The cross-tissue analysis at 5% FDR identifies 365 CpGs and 40 DMRs which demonstrate the strong relationship between the brain and blood methylation profile. Also, by focusing on 97 CpGs and 10 DMRs, the researchers discovered about half of them are located in the enhancer region. Specifically, the RIN3 gene region demonstrated strong consistency between the blood and brain which further proved the indication power of blood methylation alteration.  </p><img src="/2025/06/23/paper-interpretation-5/cognitive.png" class="" title="image here"></li><li><p>Finally, the integrative multi-omics analysis reveals the deep mechanism of DNA methylation to neurodegenerative disease. When correlating the DNA methylation with DNA region, two CpGs located in promoter regions of the PXK and SERPINB9 genes, respectively, were significantly associated with target gene expression levels at 5% FDR. The further MethReg analysis associated CpGs with the putative transcription factors and target genes. The study at 5% FDR identified a total of 8 CpG-TF-target gene triplets which involved TGF signaling, lipid metabolism, inflammatory response, and cell cycle control.</p></li></ol> <img src="/2025/06/23/paper-interpretation-5/chr.png" class="" title="image here"><p><strong>Importance and Impact</strong></p><p>Cross-tissue EWAS of brain and blood of Alzheimerâ€™s disease (AD) is one of the crucial steps to reveal the epigenetic pathways of the multifactorial neurodegenerative disease. By integrating peripheral blood and brain tissue data, the analysis identifies shared and tissue-specific DNA methylation marks for AD, guiding the role of systemic and neural epigenomic changes in disease pathogenesis and onset.</p><p>One of the most important implications of this work is the potential for blood-borne epigenetic markers to be used reliably in a non-invasive way to reflect brain changes. This holds out the promise of earlier detection, easier monitoring, and even in certain cases, the ability to treat on a patient-specific epigenetic basis. Furthermore, the discovery of methylation sites that alter similarly throughout the tissues provides a glimpse of the underlying regulatory pathways involved in the pathogenesis of AD, including inflammation, neuronal function, and immune function.</p><p>This study also supports growing acceptance that epigenetic regulation plays a key role in cognitive aging and is employable as a biomarker and modifiable risk factor. Overall, the cross-tissue approach enhances the validity of AD research and facilitates personalized medicine approaches in the prevention or slowing of neurodegeneration through epigenetic modification.</p><p><strong>[1]</strong></p><ol><li>T, C.S.; Young, J.I.; Zhang, L.; Gomez, L.; Schmidt, M.A.; Varma, A.; Chen, X.S.; Martin, E.R.; Wang, L. Cross-tissue analysis of blood and brain epigenome-wide association studies in Alzheimerâ€™s disease. <em>Nat Commun</em> <strong>2022</strong>, <em>13</em>, 4852, doi:10.1038&#x2F;s41467-022-32475-x.</li></ol>]]></content>
    
    
    <categories>
      
      <category>paper_interpretation</category>
      
    </categories>
    
    
  </entry>
  
  
  
  <entry>
    <title>usabo-2024-analysis</title>
    <link href="/2025/06/22/usabo-2024/"/>
    <url>/2025/06/22/usabo-2024/</url>
    
    <content type="html"><![CDATA[<p>USABO Analysis For 2024</p><p>2024å¹´çš„é¢˜æ™®éåéš¾ï¼Œåœ¨æ¯”èµ›æ—¶é—´å†…åšå®Œä¼šæœ‰ç‚¹ç´§å¼ ï¼ŒåŒæ—¶è‡ªä»2022å¹´èµ·ï¼ŒUSABOçš„é¢˜å°±é€å¹´å˜éš¾ï¼Œæ›´åå‘äºè€ƒå¯Ÿå¯¹äºçŸ¥è¯†çš„è¿ç”¨å’Œç†è§£ï¼Œå‡å°‘å¯¹çº¯èƒŒè¯µçŸ¥è¯†ç‚¹çš„é¢˜çš„è€ƒå¯Ÿã€‚</p><p>2024å¹´åˆ†æ•°çº¿å¦‚ä¸‹ï¼š</p><ol><li>é‡‘å¥–ï¼š25 </li><li>é“¶å¥–ï¼š20</li><li>é“œå¥–ï¼š18</li></ol><p>è·Ÿ2023å¹´å’Œ2022å¹´åšå¯¹æ¯”æ¥çœ‹æ˜¾è‘—é™ä½ï¼š</p><img src="/2025/06/22/usabo-2024/score.png" class="" title="iamge here"><p>ä½†åŒæ—¶2025å¹´USABOåˆ™ç›¸å¯¹ç®€å•ï¼Œä¹Ÿå°è¯äº†USABOä¸€å¹´éš¾ä¸€å¹´ç®€å•çš„è§„å¾‹ï¼Œä½†æŒ‰ç…§è§„å¾‹æ¥è¯´2026å¹´å°†ä¼šå˜å¾—å¾ˆéš¾ï¼Œæ‰€ä»¥å„ä½è€ƒç”Ÿè¦åšå¥½å‡†å¤‡</p><p>æ¥ä¸‹æ¥çœ‹2024å¹´é¢˜è§£ï¼š</p><img src="/2025/06/22/usabo-2024/1.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">Question 1: è€ƒå¯Ÿphospholipid bilayer å®šä¹‰ï¼Œ<br>å¯¹äºneucleolus æ¥è¯´ï¼Œå¤–å±‚è¿˜æœ‰nucleusï¼Œæ‰€ä»¥ä¸æ˜¯ç›´æ¥è¢«phospholipid bilayeråŒ…è£¹<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/2.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br><span class="line">4</span><br><span class="line">5</span><br><span class="line">6</span><br><span class="line">7</span><br><span class="line">8</span><br><span class="line">9</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 2: è¿™é“é¢˜å°±æ˜¯å±äºUSABOè¿‘å¹´æ¥æ–°åŠ å…¥çš„ç”Ÿç‰©æŠ€æœ¯æ¨¡å—ï¼ˆå¥½åƒæ˜¯2020å¹´å·¦å³å¼•å…¥çš„ï¼‰<br>é—®é¢˜é—®ä¸ºä»€ä¹ˆisolateçš„é‚£ä¸ª60dbé‡é‡çš„è›‹ç™½è´¨æ²¡èƒ½è·Ÿlane 1çš„æ¢¯åº¦å¯¹é½ï¼Ÿ<br><br>åŸå› å¾ˆç®€å•ï¼Œå°±æ˜¯æœ‰æ‚è´¨æ··åœ¨å…¶ä¸­æˆ–è€…æ¢é’ˆä¸å¤Ÿçµæ•å¯¼è‡´å‡ºç°åœ¨æ›´è½»çš„ä½ç‚¹<br>é¦–å…ˆæ’é™¤ABï¼Œnonspecificä¼šè®©ä¸œè¥¿æ›´é‡æˆ–è€…å‡ºç°ä¸€æ•´æ¡ä¸ç²¾å‡†çš„laneï¼Œä¸ä¼šè®©å®ƒæ›´è½»<br>Cé€‰é¡¹æ˜¯æ­£ç¡®çš„ï¼Œmultiple unitå¯èƒ½ä¼šåœ¨æº¶è§£è¿‡ç¨‹ä¸­åˆ†ç¦»ï¼Œå˜è½»<br>Dé€‰é¡¹é”™è¯¯ï¼Œå¿˜è®°blotå°±æ²¡æœ‰ç»“æœ<br>Eé€‰é¡¹é”™è¯¯ä¸å¤Ÿæ—¶é—´ä¼šå¯¼è‡´é¢œè‰²å˜æµ…æˆ–è€…æ²¡æœ‰ç»“æœï¼Œä¸ä¼šæ›´è½»<br><br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/3.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">qeustion 3: USABOæ­£å¸¸éš¾åº¦ï¼Œæ ¹æ®pKaç®—æ¯”ä¾‹<br>æŒ‰ç…§ä¸Šé¢çš„å…¬å¼ç®—å°±å¯ä»¥äº†<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/4.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 4: rRNAäº§ç”Ÿäºneucleolusä½†æ˜¯å¤§éƒ¨åˆ†ç”¨äºç»„è£…ribosomeæ‰€ä»¥é€‰E<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/5.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br><span class="line">4</span><br></pre></td><td class="code"><pre><code class="hljs bash">qeustion 4: USABOä¸­æ¯”è¾ƒæ€ªçš„é¢˜ï¼Œè€ƒå¯Ÿææ€§å’Œéææ€§çš„å…³ç³»<br>anionic polymersä¼šå› ä¸ºè·ŸmRNAéª¨æ¶ä¸Šçš„è´Ÿç”µå­ç›¸æ–¥ï¼Œæ‰€ä»¥ç”¨ä¸äº†<br>metal-based compoundsä¸»è¦éƒ½æ˜¯æ­£ç”µå­æ‰€ä»¥å¯ä»¥ä½¿ç”¨<br><br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/6.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 6: çº¯èƒŒè¯µé¢˜ï¼Œestrogen receptoråœ¨ç»†èƒå†…ï¼Œä¼šç›´æ¥ä½œç”¨äºDNAè½¬å½•æœºåˆ¶ï¼Œæ‰€ä»¥é€‰E<br>ABç¬¬ä¸€çœ¼æ’é™¤<br>CDçš„è¯éƒ½æ˜¯ç»†èƒè†œè¡¨é¢æ¥æ”¶å™¨ï¼Œæ‰€ä»¥æ²¡æœ‰ä½œç”¨ç‚¹<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/7.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br><span class="line">4</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 7: è¿™é“é¢˜æœ‰ç‚¹tricky<br>ä¹ä¸€çœ‹DEä¼¼ä¹éƒ½æœ‰å¯èƒ½ï¼Œ<br>ä½†æ˜¯ç›¸æ¯”äºlipidæ¥è¯´ï¼Œplant cell wallæ›´æœ‰å¯èƒ½å­˜åœ¨glycoprotein<br>ABCä¸€çœ¼æ’é™¤<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/8.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 8: USABOçš„ç”Ÿç‰©æŠ€æœ¯é¢˜<br>ç›´æ¥èƒŒè¿™ä¸ªæµç¨‹å°±å¯ä»¥äº†<br>æ¨èä¸€æœ¬ä¹¦å«biotechnology ä½œè€…æ˜¯ellyn daughertyï¼Œè¿™æœ¬ä¹¦é‡Œæœ‰åŸºæœ¬çš„ç”Ÿç‰©æŠ€æœ¯çŸ¥è¯†ï¼Œåº”ä»˜USABOç»°ç»°æœ‰ä½™<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/9.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 9: çº¯èƒŒè¯µé¢˜ï¼Œè®°ä½start codon establish reading frame<br>shine-dalgarno sequence åªæ˜¯è¾…åŠ©ribosomeç»“åˆçš„<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/10.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 10: è€ƒå¯Ÿubiquinoneçš„ä½œç”¨åœ¨å…‰åˆä½œç”¨ä¸­<br>Ubiquinoneåœ¨æ¤ç‰©ä¸­å’Œåœ¨åŠ¨ç‰©ä¸­ä½œç”¨å·®ä¸å¤šï¼Œéƒ½æ˜¯è´Ÿè´£ä¼ é€’ç”µå­çš„ï¼Œæ‰€ä»¥ç¬¬ä¸€ä»¶äº‹çœ‹åˆ°çš„ä¸€å®šæ˜¯æ°§åŒ–ä»·ä¸å˜<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/11.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br><span class="line">4</span><br><span class="line">5</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 11: è€ƒå¯Ÿæ¤ç‰©ä¿¡æ¯ç´ çš„ä½œç”¨ï¼Œå»ºè®®campbellè¿™ä¸€ç« èŠ‚ä¸Šå†…å®¹è¦å…¨éƒ¨èƒŒè¯µ<br>è¿™é“é¢˜ç­”æ¡ˆå­˜ç–‘ï¼Œ å¤§æ¦‚ç‡æ˜¯E<br>ä¸»è¦åœ¨Bé€‰é¡¹å’ŒEé€‰é¡¹ä¹‹é—´çº ç»“<br>ä½†è€ƒè™‘åˆ°abscisic acid å’Œ IAAä¼šç›¸äº’ä½œç”¨<br>Eé€‰é¡¹æ­£ç¡®ç‡æ›´å¤§<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/12.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 12: è€ƒå¯Ÿæ¤ç‰©å¹²æ—±æ¡ä»¶ä¸‹çš„ç‰¹å¾<br>ABCDEéƒ½æ˜¯å¯¹å¹²æ—±çš„é€‚åº”ï¼Œä½†è€ƒè™‘åˆ°æ˜¯åœ¨è½å¶æ—ç¯å¢ƒä¸­ï¼Œè·Ÿæ²™æ¼ ä¸å¤ªä¸€æ ·ï¼Œè€Œä¸”Cé€‰é¡¹æ›´å¤šè§äºæ›´åŠ æ¹¿æ¶¦çš„åœ°æ–¹ï¼Œæ‰€ä»¥é€‰C<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/13.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br><span class="line">4</span><br><span class="line">5</span><br><span class="line">6</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 13ï¼šè€ƒå¯Ÿæ°´åˆ†ç›¸å…³çš„ååº”<br>é¦–å…ˆæ›´å¤šæ°´åˆ†ä¿æŒåœ¨induismä¸‹è¯´æ˜è¦ä¹ˆæ˜¯æ›´å¤šæ°´äº§ç”Ÿï¼Œè¦ä¹ˆæ˜¯æ›´å°‘æµå¤±<br>æ‰€ä»¥æ’é™¤é€‰é¡¹AB<br>CDEä¸­å¯ä»¥æ’é™¤Cï¼Œå› ä¸ºå‘¼å¸ä½œç”¨çš„æ°´åˆ†ç»å¤§éƒ¨åˆ†ä¼šæµå¤±<br>DEä¸­æˆ‘æ›´åå‘äºDï¼Œä½†æ˜¯ç­”æ¡ˆç»™çš„æ˜¯Eï¼Œå¯èƒ½æ˜¯ç”±äºvascular transport ä¼šé€ æˆæµå¤±åŠ å‰§å› ä¸ºæœ‰transpirationçš„å­˜åœ¨<br><br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/14.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 14: è€ƒå¯ŸABCå®šç†<br>åªæœ‰Bé€‰é¡¹æ­£ç¡®ï¼Œå› ä¸ºaggregate foodæœè‚‰ä¾èµ–äºcarpelçš„å¤§å°å’Œå…¶ä»–éƒ¨åˆ†çš„å æ¯”<br>ABDEéƒ½æ˜¯é”™çš„<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/15.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 15: è€ƒå¯Ÿæ¤ç‰©çš„å…ç–«ååº”ï¼Œè¿™ä¸ªç‚¹ä¸ç»å¸¸è€ƒä½†è¿˜æ˜¯å»ºè®®çœ‹ä¸€ä¸‹<br>phytoalexin production <span class="hljs-keyword">in</span> response to flagellin æ˜¯PTI ï¼ˆPAMP-Triggered Imunityï¼‰ä¸­çš„ä¸€éƒ¨åˆ†ï¼Œä¸æ˜¯effector-triggeredé‡Œçš„<br><br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/16.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br><span class="line">4</span><br><span class="line">5</span><br><span class="line">6</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 16: è€ƒå¯Ÿethylene reponse<br>ethyleneçš„ä½œç”¨æ˜¯å¯¹äºå‹åŠ›åŠ æ•æ„Ÿï¼Œæ‰€ä»¥ä¼šé•¿å¾—æ›´çˆ±<br>ctrçš„æ•ˆæœä¼šå¤§äºethylene<br>å¯¹äºABæ¥è¯´ä¸€å®šä¼šäº§ç”Ÿshort offspring<br>å¯¹äºDEæ¥è¯´ctrå’Œeiné€šè·¯ä¸ä¸€æ ·ï¼Œæ‰€ä»¥ä¹Ÿä¼šå˜çŸ®ï¼ŒEé€‰é¡¹ä¹Ÿä¼šå˜çŸ®<br>Cé€‰é¡¹æ­£ç¡®æ˜¯å› ä¸ºeinä¼šé˜»æŒ¡etoç”Ÿæ•ˆï¼Œå¯¼è‡´æ¤ç‰©ä¸ä¼šå˜çŸ®<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/17+18.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 17ï¼š è€ƒå¯Ÿæ¤ç‰©å±‚çº§å…³ç³»ï¼Œæ ‘çš®å’Œsecondary phloemæ˜¯æ¯”è¾ƒæ–°é•¿å‡ºæ¥çš„ï¼Œheart woodæ˜¯æœ€durableçš„<br>question 18ï¼š è€ƒå¯Ÿèƒšèƒå‘è‚²ï¼Œ ZPAå’ŒAERä¸ä¼šé€ æˆå½±å“ï¼ŒZPA and AERæ˜¯ç¡®å®šå‰åä½ç½®å…³ç³»çš„ï¼Œä¸ä¼šé€ æˆæ›´å¤šçš„å…³èŠ‚äº§ç”Ÿ<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/19.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br><span class="line">4</span><br><span class="line">5</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 19: sliding flimaent modelåˆ†å¾ˆå¤šé˜¶æ®µå¦‚ä¸‹å›¾æ‰€ç¤º<br>Bé€‰é¡¹é”™è¯¯ï¼Œmyosin + ATPæ˜¯lowenergy stateï¼Œ å’ŒADPç»“åˆæ‰æ˜¯high energy state<br>Cé€‰é¡¹é”™è¯¯ï¼ŒADPå’ŒPiåˆ†ç¦»æä¾›é©±åŠ¨åŠ›<br>Dé€‰é¡¹é”™è¯¯ï¼Œè·ŸPiç»“åˆæ‰ä¼šè¿›å…¥é«˜èƒ½çº§çŠ¶æ€<br>Eé€‰é¡¹é”™è¯¯ï¼ŒCaç¦»å­ä¸è·Ÿtropomyosinç»“åˆ<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/filament.png" class="" title="image here"><img src="/2025/06/22/usabo-2024/20.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">qeustion 20:<br>å½“ç›´æ¥è¿›å…¥è¡€æ¶²å¾ªç¯çš„æ—¶å€™ï¼Œlymph nodeä¸ä¼šç›´æ¥æ¢æµ‹ï¼Œè€Œæ˜¯å…ˆæµç»spleenæ—¶æ‰ä¼šäº§ç”Ÿå…ç–«ååº”<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/21.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br><span class="line">4</span><br><span class="line">5</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 21:<br>ABé€‰é¡¹ç›´æ¥æ’é™¤ï¼ŒAé€‰é¡¹è¦æµè¿‡æ•´ä¸ªèº«ä½“ï¼ŒBé€‰é¡¹è¡€æ¶²åœ¨è‚ºå¾ªç¯ä¸­åªä¼šé€‰æ‹©å·¦è¾¹æˆ–å³è¾¹<br>Cé€‰é¡¹æ’é™¤ï¼Œliver å’Œ adrenal glandä¸äº’é€š<br>Dé€‰é¡¹æ­£ç¡®ï¼Œsmall intesting åˆ°liveråªç”¨èµ°hepatic veinå°±å¯ä»¥äº†<br>Eé€‰é¡¹é”™è¯¯ï¼Œèƒƒå’Œè„¾çš„è·ç¦»æ¯”small intestin å’Œliveré•¿<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/22.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br><span class="line">4</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 22: è€ƒåœºäººä½“æ°´å¹³è¡¡<br>é—®è‚¾è„ä¸­é‚£ä¸ªéƒ¨åˆ†ä¼šç”¨åˆ°èƒ½é‡<br>ascending loopä¸­reabsorptionéœ€è¦èƒ½é‡ç”¨active intake<br><br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/23.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br><span class="line">4</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 23: è€ƒå¯Ÿè·Ÿè¡€æ¶²æœ‰å…³çš„ç—‡çŠ¶<br>bottom layerä»£è¡¨è¡€çº¢ç»†èƒï¼Œ<br>è¡€çº¢ç»†èƒå¢å¤šè¯´æ˜è¦ä¹ˆæ˜¯plasmaå‡å°‘æ‰€ä»¥percentageå¢å¤šï¼Œè¦ä¹ˆæ˜¯æœ¬èº«æ•°é‡å¢å¤š<br>æ‰€ä»¥é€‰C<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/24.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 24:çº¯èƒŒè¯µçš„é¢˜<br>è¤ªé»‘ç´ å½±å“ç¡çœ ï¼Œtryptophanäº§ç”Ÿè¤ªé»‘ç´ <br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/25.png" class="" title="image here"><figure class="highlight less"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br><span class="line">4</span><br><span class="line">5</span><br></pre></td><td class="code"><pre><code class="hljs less"><span class="hljs-selector-tag">question</span> <span class="hljs-number">25</span>:è€ƒå¯Ÿå…ç–«ååº”ï¼Œ<span class="hljs-selector-tag">CD8</span>ç”¨äºè¯†åˆ«<span class="hljs-selector-tag">pathogen</span>æˆ–è€…æ„ŸæŸ“å®¿ä¸»ç»†èƒ<br><span class="hljs-selector-tag">A</span>é€‰é¡¹æ’é™¤ï¼Œ<span class="hljs-selector-tag">CD8</span>åœ¨ç»†èƒè¡¨é¢<br><span class="hljs-selector-tag">B</span>é€‰é¡¹æ’é™¤ï¼Œ<span class="hljs-selector-tag">CD8</span> <span class="hljs-selector-tag">bind</span> <span class="hljs-selector-tag">to</span> <span class="hljs-selector-tag">MHC</span> <span class="hljs-selector-tag">I</span><br><span class="hljs-selector-tag">D</span>é€‰é¡¹æ’é™¤ï¼Œå®ƒçš„å½¢çŠ¶åŸºæœ¬å›ºå®šï¼Œå› ä¸ºä¸€èˆ¬åªä¼šè¯†åˆ«å®¿ä¸»ç»†èƒä¸Šçš„ç‰¹å®šå› å­æ¯”å¦‚ <span class="hljs-selector-tag">MHC</span> <span class="hljs-selector-tag">I</span><br><span class="hljs-selector-tag">E</span>é€‰é¡¹æ’é™¤ï¼Œ<span class="hljs-selector-tag">HIV</span>ä¸ä¼šå¯¹<span class="hljs-selector-tag">CD8</span> é€ æˆå½±å“<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/26.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 26:ç¥ç»ç§‘å­¦ï¼ŒèƒŒè¯µé¢˜<br>thylamusä¼šæ”¶é›†å„ä¸ªæ„Ÿå®˜ä¼ è¾“åˆ°å¤§è„‘çš„ä¿¡å·ï¼Œç„¶ååœ¨ä¼ è¾“ç»™ç‰¹å®šåŒºåŸŸ<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/27.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 27: é€åˆ†é¢˜<br>bohr <span class="hljs-built_in">shift</span>ï¼Œdecrease pH or increase CO2 concentration <br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/28.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 28: è€ƒå¯Ÿäººä½“æ¿€ç´ <br>é—®å“ªç§æ¿€ç´ æ˜¯è·Ÿandrogenæœ‰å…³<br>é€‰Eï¼Œå› ä¸ºGnRHä¼šè¢«androgenæ€§è´¨çš„LHå’ŒFSHæŠ‘åˆ¶<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/29.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 29ï¼šèƒŒè¯µé€åˆ†é¢˜<br>resting potential è·ŸK+ç¦»å­é€šé“æœ‰å…³ä¸»è¦åŸç†æ˜¯è®©potassiumæµå¤±ï¼ŒACEé¦–å…ˆæ’é™¤<br>ç„¶åDé€‰é¡¹æ˜æ˜¾é”™è¯¯ï¼Œé”™ç”¨ç›¸å<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/30.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 30: èƒŒè¯µé¢˜ï¼Œè€ƒå¯Ÿäººä½“å™¨å®˜ä½œç”¨<br>lipaseåœ¨pancreaseä¸­äº§ç”Ÿ<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/31.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 31: è€ƒå¯Ÿç”Ÿç‰©è¡Œä¸ºå­¦<br>æ ¹æ®å…‰æ¥è°ƒèŠ‚è¡Œä¸ºï¼ŒåŒæ—¶è¿˜æœ‰synchronisationçš„å­—çœ¼ï¼Œå¾—çŸ¥æ˜¯å¹´èŠ‚å¾‹è¡Œä¸º<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/32.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 32:è€ƒå¯Ÿç”Ÿç‰©è¡Œä¸º<br>å¯ä»¥çœ‹å‡ºæ˜¯è¦æ‰¾é£Ÿç‰©ï¼Œæ‰€ä»¥é€‰B<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/33.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 33:è€ƒå¯Ÿç”Ÿç‰©è¡Œä¸º<br>peripatric specieså·²ç»æ˜¯ä¸ªæ–°ç‰©ç§äº†ï¼Œé‡æ–°å¼•å…¥ä¸ä¼šå¯¼è‡´å¢å¼º<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/34.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 34: è€ƒå¯Ÿé—ä¼ å­¦è§„å¾‹ï¼Œ<br>è¿™é“é¢˜å­˜ç–‘ï¼Œå®˜æ–¹ç­”æ¡ˆæ˜¯Eï¼Œä½†æœ¬äººè®¤ä¸ºæ›´æœ‰å¯èƒ½æ˜¯Dï¼Œç›®å‰ä¸åšè§£æ<br><br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/35.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br><span class="line">4</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 35: è€ƒå¯ŸX-<span class="hljs-built_in">link</span> gene<br>æ¯äº²æ˜¯allele carrier<br>çˆ¶äº²æ˜¯è‰²ç›²<br>æ‰€ä»¥æœ‰0.5çš„å‡ ç‡æ˜¯è‰²ç›²ï¼Œ0.5çš„å‡ ç‡ä¸æ˜¯<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/36.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 36:è€ƒå¯Ÿhardy weinburg equilibriumï¼Œé€åˆ†é¢˜<br>ç›´æ¥ç”¨å…¬å¼ç®—å°±å¯ä»¥<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/37.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 37: <br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/38.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 38:å¦‚å›¾æ‰€ç¤ºï¼ŒåŸºæœ¬æ¦‚ç‡è®º<br><br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/39.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 39: äººå·¥çš„æ“ä½œï¼Œdirectional selectionæ˜¯è‡ªç„¶çš„æ“ä½œ<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/40.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 40: ducheme muscular dystrophyæ˜¯X-<span class="hljs-built_in">link</span> recessive<br>å¦‚æœæ˜¯X-<span class="hljs-built_in">link</span> recessiveçš„è¯ï¼Œç¬¬ä¸‰ä»£ä¸¤ä¸ªfemaleä¸ä¼šå¾—ç—…<br>æ³¨æ„ä¸fragile X syndromeåŒºåˆ†ï¼Œfragile X syndrome æ˜¯X-dominanté—ä¼ <br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/41.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 41: è€ƒå¯Ÿè¿›åŒ–å­¦<br>æ²¡æœ‰ä»»ä½•fitnesså˜åŒ–åªæœ‰å°½å¯èƒ½æ—¶neurtral<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/42.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 42: è€ƒå¯Ÿè¿›åŒ–è®º<br>ç—…æ¯’ä¼šè¿›åŒ–çš„å¢å¼ºä¼ æ’­èƒ½åŠ›ä½†æ˜¯å°½å¯èƒ½å‡å°‘å®¿ä¸»æ­»äº¡ç‡ï¼Œå®ç°æ›´å¥½çš„ç”Ÿå­˜æ€§<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/43.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 43: è€ƒå¯Ÿecology<br>è—»ç±»æ˜¯åº•å±‚ç”Ÿç‰©ï¼Œbottom up regulation çš„ç‰¹å¾æ˜¯åº•å±‚ç”Ÿç‰©ç¹æ®–é€Ÿåº¦å¾ˆå¿«<br>è™½ç„¶å¤§é‡æ­»äº¡ï¼Œä½†ä¸ä¼šé€ æˆæ˜¾è‘—å½±å“ï¼Œä¼šå› ä¸ºé«˜ç¹æ®–ç‡å¼¥è¡¥æŸå¤±<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/44.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 44: è€ƒå¯Ÿecology<br>æ˜æ˜¾çœ‹åˆ° richnesså¢åŠ ï¼Œå‡åŒ€åº¦å‡å°‘<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/45.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br><span class="line">4</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 45: è€ƒå¯Ÿecology<br>K-selection: quality over quantity, close to capacity <br>r-selection: quantity over quality, far from capacity<br>æ˜¾è€Œæ˜“è§ï¼Œé€‰A<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/46.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">quesiton 46: è€ƒå¯Ÿecology<br>epiphyteå±äºå…±ç”Ÿå…³ç³»åŒæ–¹ä¸å—å½±å“ï¼Œé€‰B<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/47.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 47: è€ƒå¯Ÿecology<br>ç£·å¾ªç¯è·Ÿåå‘äºåŒºåŸŸåŒ–æ˜¯å› ä¸ºphosphrous particleä¼šè·ŸåœŸå£¤åˆ†å­ç´§å¯†ç»“åˆï¼Œä¸ä¼šæœ‰é€”å¾„å‘å¤–æ‰©æ•£<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/48.png" class="" title="image here"><figure class="highlight apache"><table><tr><td class="gutter"><pre><span class="line">1</span><br></pre></td><td class="code"><pre><code class="hljs apache"><span class="hljs-attribute">question</span> <span class="hljs-number">48</span>: çº¯èƒŒè¯µé¢˜ï¼Œå»ºè®®æ”¾åœ¨æœ€åå‡†å¤‡ï¼Œå› ä¸ºèƒŒäº†ä¹Ÿä¸ä¸€å®šæ‹¿åˆ†ï¼Œè€Œä¸”å†…å®¹å¾ˆå¤š<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/49.png" class="" title="image here"><figure class="highlight apache"><table><tr><td class="gutter"><pre><span class="line">1</span><br></pre></td><td class="code"><pre><code class="hljs apache"><span class="hljs-attribute">question</span> <span class="hljs-number">49</span>: çº¯èƒŒè¯µé¢˜ï¼Œå»ºè®®æ”¾åœ¨æœ€åå‡†å¤‡ï¼Œå› ä¸ºèƒŒäº†ä¹Ÿä¸ä¸€å®šæ‹¿åˆ†ï¼Œè€Œä¸”å†…å®¹å¾ˆå¤š<br></code></pre></td></tr></table></figure><img src="/2025/06/22/usabo-2024/50.png" class="" title="image here"><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br></pre></td><td class="code"><pre><code class="hljs bash">question 50: çº¯èƒŒè¯µé¢˜ï¼Œå»ºè®®æ”¾åœ¨æœ€åå‡†å¤‡ï¼Œå› ä¸ºèƒŒäº†ä¹Ÿä¸ä¸€å®šæ‹¿åˆ†ï¼Œè€Œä¸”å†…å®¹å¾ˆå¤š<br></code></pre></td></tr></table></figure>]]></content>
    
    
    <categories>
      
      <category>usabo</category>
      
    </categories>
    
    
  </entry>
  
  
  
  <entry>
    <title>paper-interpretation-4</title>
    <link href="/2025/06/22/paper-interpretation-4/"/>
    <url>/2025/06/22/paper-interpretation-4/</url>
    
    <content type="html"><![CDATA[<p>This is the last paper interpretation in the transgenerational epigenetic inheritance topic, it is about the small RNA differential expression interferes transgenerationally with the offspring behavior, and the source of environmental stress is the pathogenic infection. Compared to the previous studiesâ€™ environmental stress or interference factor, this paper investigates the pathogenic infection effect which is a big factor in the environment that is not often focused on by other studies. </p><p>The paper Pathogenic Infection in Male Mice Changes Sperm Small RNA Profiles and Transgenerationally Alters Offspring Behavior(Tyebji et al., 2020) is written by Tyebji et al. and the focus on the small RNA differential expression topic is also a field that needs a more thorough research like this paper.</p> <img src="/2025/06/22/paper-interpretation-4/abstract4.png" class="" title="image here"><p><strong>Research Background</strong></p><p>Several researchers before have pointed out the potential of pathogenic infection to hijack the epigenetic regulation system of the host cells hence causing the epigenetic trait to change accordingly. Also, the effect of sperm was more focused by the studies and demonstrated its strong ability to affect the offspring epigenetic profile which people previously thought that sperm exhibited less effect compared to the ovule. However, the recorded paper only reported the intergenerational effect of the pathogenic infection but ignored the potential of the transgenerational effect from other kinds of pathogenic infection.</p><p><strong>Experiment Object</strong></p><p>The researchers want to demonstrate that Toxoplasma will alter the sperm RNA profile and will pass the effect to the subsequent generations instead of only intergenerationally. Also, the experiment wants to determine what trait change will result from the RNA profile change across the generation and investigate specifically which kinds of families of small RNA will cause the effect. </p><p><strong>Experiment result</strong></p><ol><li><p>For the first-generation mice after infection, the sperm content produced by the male mice is lower than the control group and may lead to an increased rate of infertility. The sperm is also observed to have increased abnormalities compared to the control group of mice which manifests the effect of the infection on sperm. For the next generation which is the F1 generation mice of the infected male mice, behavioral changes, like developing psychiatric disorders and increased anxiety which were demonstrated by less center time in open field tests, indicated that the infection caused gene expression change in the second generation. Not only the F1 generation but also the F2 generation demonstrated similar behavioral changes similar to the parental mice. </p><img src="/2025/06/22/paper-interpretation-4/sperm.png" class="" title="image here"><img src="/2025/06/22/paper-interpretation-4/object.png" class="" title="image here"></li><li><p>Back to the F0 generation, small RNA profile alteration is observed in the F0 generation. With 25.88% of small RNA differentially regulated, 9.21% up-regulated and 16.67% down-regulated, the difference between the normal and infected F0 mice is apparent. Further quantitative analysis shows that enriched small RNA is observed with the majority of tRNA followed by miRNA and piRNA recorded. Also, 36 pathways about the small RNA are also shown to be enriched compared to the normal F0 generation, and these pathways are involved in reproduction, male gamete development and maturation, and cellular organization.</p><img src="/2025/06/22/paper-interpretation-4/volcano.png" class="" title="image here"></li><li><p>To further investigate the effect of small RNA, researchers performed microinjection of small RNA to investigate the inner mechanism. The healthy male mice injected with the small RNA from the infected series demonstrated increased impairment in object recognition memory. For the female mice injected with the infected small RNA series, increased anxiety-like behavior is observed like spending less time in the lighted areas compared to the normal female mice. </p><img src="/2025/06/22/paper-interpretation-4/KEGG.png" class="" title="image here"></li></ol><img src="/2025/06/22/paper-interpretation-4/open-field.png" class="" title="image here"> <p><strong>Possible Mechanism</strong></p><p>Based on the result observed in the previous experiment, the researchers concluded that the Toxoplasma infection will cause cognitive impairment in both male and female offspring as well as reshaping the zygotic development of mice. The impairment and reshaping process is caused by the small RNA differential expression in male sperm, this differential expression process will be passed to F1 and F2 generation as well.</p><p><strong>Importance and Impact</strong></p><p> The finding that infection of males with pathogens alters sperm small RNA profiles and, in turn, offspring behavior trans-generationally is an important advance in our understanding of how the fatherâ€™s experience impacts the next generation. In demonstrating that a nongenetic environmental stressor, infection, can reprogram the small RNA cargo of sperm, this research reveals a nongenetic mechanism for encoding and transmitting environmental information to offspring.</p><p>The changes demonstrated by the offspring reveal that environmental exposure and paternal health produce long-term psychological and neurological impacts on offspring. This is counter to the previous assumption that only maternal influences play a major role during the early development stages and introduces a new factor for paternal contribution towards inherited traits.</p><p>Most importantly, this research puts small RNAs at the center of genome-to-environment intergenerational communication. The research also opens new avenues for understanding how stress, diet, or toxins might share germ cell reprogramming and affect offspring health. Clinically, the research emphasizes the importance of male health at conception and suggests that targeting infection or inflammation in men might have protective effects on offspring health. Broadly, this research redefines the heredity paradigm, with the germline as an active and adaptive participant to environmental inputs.</p><p>Tyebji, S., Hannan, A. J., &amp; Tonkin, C. J. (2020). Pathogenic Infection in Male Mice Changes Sperm Small RNA Profiles and Transgenerationally Alters Offspring Behavior. <em>Cell Reports</em>, <em>31</em>(4). <a href="https://doi.org/10.1016/j.celrep.2020.107573">https://doi.org/10.1016/j.celrep.2020.107573</a></p>]]></content>
    
    
    <categories>
      
      <category>paper_interpretation</category>
      
    </categories>
    
    
  </entry>
  
  
  
  <entry>
    <title>Paper-Interpretation-3-Transgenerational transmission of reproductive and metabolic dysfunction in the male progeny of polycystic ovary syndrome</title>
    <link href="/2025/06/21/paper-interpretation-3/"/>
    <url>/2025/06/21/paper-interpretation-3/</url>
    
    <content type="html"><![CDATA[<p>This is the third paperâ€™s interpretation of transgenerational epigenetic inheritance. This paper is about the reproductive and metabolic dysfunction that passed transgenerationally due to polycystic ovary syndrome. This paper, unlike the previous two, includes the observation and data collection on humans, which is rarely seen in the TEI research field as experiment or observation including humans across several generations is commonly considered costly and inconvenient. </p><p>In the paper â€œTransgenerational transmission of reproductive and metabolic dysfunction in the male progeny of polycystic ovary syndrome(Risal et al., 2023)â€, the researchers use mice as models in replace of humans to verify the observation that the son of the polycystic ovary syndrome will increase the chance of getting obese. The researchers also verified that the small RNA expression change induces this transgenerational effect. At the same time, the effect is on the maternal side rather than the paternal side which is not similar to the previous two papers.</p> <img src="/2025/06/21/paper-interpretation-3/abstract3.png" class="" title="image here"><p><strong>Research Background</strong></p><p>Polycystic ovary syndrome is a disease that causes infertility in females and often induces other kinds of diseases like type 2 diabetes. The disease is commonly linked with syndromes like being overly obese which the researchers also observed in the offspring of the patients. Also, recent studies have found that the genetic factors for PCOS will also increase the risk of cardiovascular disease, and ÃŸ-cell dysfunction. A similar obesity syndrome is also observed across the generation as far as to F3 generation indicated by some researchers.</p><p><strong>Experiment Object</strong></p><p>In this experiment, the researchers want to determine the deep mechanism for the young age obesity of the child of a PCOS woman and also identify differentially expressed genes of small RNA through the GWAS associative analysis. Then the researchers will turn to the mice model by using prenatal androgen exposure to mimic the PCOS syndrome and showing that the obesity effect will be passed transgenerationally to F3 generation and which mechanism takes for this transgenerational effect. </p><p><strong>Experiment Result</strong></p><ol><li>The PCOS son will have an altered lipid circulation profile compared to the normal child. The data sample indicates the increased cholesterol concentration and circulation of low-density lipoprotein(LDL) for the PCOS sons. Also as the mother has a higher BMI which indicates obesity, the son of the obese mother will also have a higher BMI compared to the control group child with the motherâ€™s BMI lower than 25.</li></ol><img src="/2025/06/21/paper-interpretation-3/obese.png" class="" title="image here"><ol start="2"><li>The researchers then used the sncRNA analysis of the serum of PCOS son identify miRNA targeted loci risk gene of PCOS. hsa-miR-1299, hsa-miR-122-5p, hsa-miR-199b- 3p, hsa-miR-199a-5p, hsa-miR-1307-3p, hsa-miR-96- 5p, and hsa-miR-548ar-3p are the 7 DEmiRNA that found both in PCOS son and PCOS mother which indicates the potential of these 7 DEmiRNAs as the factor gene for PCOS.</li></ol><img src="/2025/06/21/paper-interpretation-3/chart.png" class="" title="image here"><img src="/2025/06/21/paper-interpretation-3/graph.png" class="" title="image here"><ol start="3"><li>Using the mice model, the researchers found that PCOS will cause transgenerational reproductive syndrome in the next generation. The lower testis weight is observed in these PCOS mice offspring F1 and F2 generation, even the only slight difference is observed in the F3 generation, the profound effect of androgenized and obesity still exists by decreasing the fertility rate and also lowering the testis weight. When the paternal is treated with androgen and the maternal side is also in obesity, transgenerationally metabolic dysfunction is also observed in the offspring and the syndrome like higher liver triglyceride is also observed in the F3 generation.</li></ol> <img src="/2025/06/21/paper-interpretation-3/miRNA-dif.png" class="" title="image here"><p><strong>Possible Mechanism</strong></p><p>The potential mechanism for this transgenerational inheritance is thought to be due to the differentially expressed miRNA and piRNA. This miRNA differential expression is passed down generational through the oocyte and affects the mtRNA in the oocyte and hence affects the offspring. The obesity of the mother can be treated as an environmental stress that alters the genetic expression within the embryo and leads them to experience trait change to accommodate this new environment.</p> <img src="/2025/06/21/paper-interpretation-3/mechanism3.png" class="" title="image here"><p><strong>Importance and Impact</strong></p><p> The study of transgenerational transmission of reproductive and metabolic dysfunction across male offspring of polycystic ovary syndrome (PCOS) provides strong evidence concerning the impact of maternal health status on offspring beyond the generation immediately affected. No longer a disease of concern only to female reproductive health, PCOS is now shown to have long-term impacts on male offspring in terms of fertility, hormone level, and metabolic profile.</p><p>This research emphasizes that PCOS should not be perceived merely as an ovarian dysfunction in females but rather as an illness having systemic and inheritable implications. Evidence of disruption of metabolism and fertility in male offspring provides evidence of epigenetic mechanisms in transmitting responses to hormonal disruption in the mother. This evidence may shift clinic perception, potentially to earlier and family-centered therapy in managing PCOS.</p><p>Moreover, this research contributes to the expanding body of evidence supporting the influence of prenatal and perinatal conditions as the principal predictors of long-term health. This research also necessitates increased caution and tracking of those children born to persons afflicted with endocrine or metabolic disorders. Lastly, the research provides further depth into the transmission of disease and introduces such timely questions as prevention, diagnosis, and treatment procedures in both sexes and across generations.</p><p>Risal, S., Li, C., Luo, Q., Fornes, R., Lu, H., Eriksson, G., Manti, M., Ohlsson, C., Lindgren, E., Crisosto, N., Maliqueo, M., EchiburÃº, B., Recabarren, S., Petermann, T. S., Benrick, A., Brusselaers, N., Qiao, J., Deng, Q., &amp; Stener-Victorin, E. (2023). Transgenerational transmission of reproductive and metabolic dysfunction in the male progeny of polycystic ovary syndrome. <em>Cell Reports Medicine</em>, <em>4</em>(5). <a href="https://doi.org/10.1016/j.xcrm.2023.101035">https://doi.org/10.1016/j.xcrm.2023.101035</a></p>]]></content>
    
    
    <categories>
      
      <category>paper_interpretation</category>
      
    </categories>
    
    
  </entry>
  
  
  
  <entry>
    <title>Paper Interpretation-2-RNA-Dependent Intergenerational Inheritance of Enhanced Synaptic Plasticity after Environmental Enrichment</title>
    <link href="/2025/06/20/Enrichment/"/>
    <url>/2025/06/20/Enrichment/</url>
    
    <content type="html"><![CDATA[<p>This is the second interpretation about the article in Transgenerational epigenetic inheritance (TEI) area, planning to do 4 paper interpretation within this area and then shift to next area like the maize production, genetic engineering, biological engineer etc.</p><p>This paper is relatively â€˜rareâ€™ in the field of TEI, as it focuses on the effect of positive environmental stimulation on the transgenerational effect on mice. The environmental enrichment (EE) is presented to be effective to improve miceâ€™s cognitive ability and other behavior through affecting the miR212&#x2F;132 families. </p><p><strong>Research background</strong></p><p>The environmental enrichment is long been observed to increase the cognitive abilities in both human and mice. It is though that the effect of EE is related to the plasticity of hippocampus and the response of hypothalamic-pituitary-adrenal axis. Also, the EE has effect on decreasing the chance of getting cognitive disease in later stage life of mice. Combining the above knowledge with the recent evidence about the small RNA transgenerational effect in gamete makes the researchers hypotheses that the effect of EE may pass to next generation or further generation using TEI. </p><p><strong>Experiment Object</strong></p><p>The object of this experiment is to determine whether the effect of EE will transfer to the further generation and also testing for the effect of EE on animal behavior. The TEI effect will be further analysis for the deeper mechanism that cause it and the analysis towards the small interfering RNA is also essential in this study. </p><p><strong>Experiment Result</strong></p><ol><li><p>EE training of the mice will increase the hippocampal synaptic plasticity through an intergenerational manner from the F0 generation to the F1 generation. The apparent enhancement in the field EPSP when comparing the EE training group with the control group indicate the effect is past to the second generation. However, the difference is vanished when observing the second generation F2 generation which indicates that effect is only happening intergenerationally.</p><p><img src="/2025/06/20/Enrichment/abstract.png" alt="image here"></p><img src="/2025/06/20/Enrichment/pie.png" class="" title="image  here"></li><li><p>The EE is transferred using sperm which indicates the male side effect on the first generation offspring. Also, apparent increase in expression of miR212&#x2F;132 is observed in both sperm and hippocampus of the F1 generation, while if the RNAi is injected into sperm, the increasing expression is not observed in the F1 generation, the field EPSP is returned to the normal value similar to the control group.</p></li></ol><p><img src="/2025/06/20/Enrichment/F1.png" alt="image here"> </p><img src="/2025/06/20/Enrichment/inhibitor.png" class="" title="image here"><p><strong>Possible Mechanism</strong></p><p>The intergenerational inheritance scheme fit the natural selection and rule, the nature would not allow enhancement in cognitive ability to persist if the environmental change and needs other adaptation to cater the new condition. The precise mechanism of how sperm small RNA differential expression generate and how this differential expression scheme persist to the next generation remain determined for this experiment. To note that, the miR212&#x2F;132 play a role in cognitive ability which verifies their differential expression is the cause of the EE. </p><img src="/2025/06/20/Enrichment/traingle.png" class="" title="image here"><p><strong>Importance and Impact</strong></p><p>The discovery that RNA-dependent mechanisms underlie the intergenerational transmission of increased synaptic plasticity after environmental enrichment is a key advance in neuroscience and epigenetics. What the research shows is that beneficial cognitive experienceâ€”like enriched environmentsâ€”can influence the operation of the brain not just in the treated individual but also offspring, through non-DNA-sequence-based mechanisms.</p><p>The involvement in RNA pathways of these enhancements suggests a crucial role of epigenetic regulation in neuroplasticity. These processes upend traditional models of heredity by showing that experiential-acquired neural traits, previously considered non-heritable, are inheritable to subsequent generations. This has serious applications for how experiences such as education, stress, or trauma may influence descendents on the molecular and cognitive levels.</p><p>Moreover, this research opens up new lines of therapeutic intervention into RNA-mediated mechanisms for enhancing cognitive performance or intergenerational resilience. The research draws attention to the dynamic interaction of environment, gene control, and behavior, and stands as a paradigm for ongoing research into mechanisms by which life experience may exert enduring, transmissible influences on brain function. The research also indicates that environmental enrichment can be harnessed as a transgenerational cognitive-enhancement strategy.</p>]]></content>
    
    
    <categories>
      
      <category>paper_interpretation</category>
      
    </categories>
    
    
  </entry>
  
  
  
  <entry>
    <title>Paper Interpretation-Piwi/PRG-1 Argonaute and TGF-b Mediate Transgenerational Learned Pathogenic Avoidance</title>
    <link href="/2025/06/19/paper-interpretation-1/"/>
    <url>/2025/06/19/paper-interpretation-1/</url>
    
    <content type="html"><![CDATA[<p>This is a brief interpretation for the beginner in the research area that may not be quite understand the working mechanism of transgenerational epigenetic inheritance (TEI) or other mechanism that related to this large research scope. The interpretation will be based on each research article and the content will be mainly focused on these sectors: Experiment method, Paperâ€™s research object and result, mechanism tested, explanation for result and Importance of the paper. The paper interpretation will inevitably to use some graph or dataset present in the article to make sure the explanation is clear, these graph and data will not be used to generate new scientific content. The interpretation is just a showcase of how I read, understand and analysis this paper. </p><p>Here is the first paper, â€œPiwi&#x2F;PRG-1 Argonaute and TGF-b Mediate Transgenerational Learned Pathogenic Avoidanceâ€ Moore et al. (Moore et al., 2019). The download link is for this paper and it is also free access version available for all researchers. This article is kind of one of the most important articles in TEI area and also the first article I read about the TEI. </p><p><strong>Research Background</strong></p><p>RNAi related TEI phenomenon is been widely observed from various animals and also experiments, ranging from different small noncoding RNA like piRNA, siRNA, tiRNA, microRNA etc. Choosing C. elegan as experiment subject is due to its easiness to control and also low cost to produce large amount of it. Also, the avoidance behavior of C. elegan towards P14 Pseudomonas can be treated as a learning behavior but also as a strong enough environmental stress that may cause genetic expression change within the C. elegan. </p><p><strong>Experiment Object</strong></p><p>The experiment is about testing the epigenetic transmission mechanism within C. elegans under the environmental stress like Pseudomonas. The Pseudomonas is presented to be attractive to the C. elegans but the toxicity within it is strong enough to change the epigenetic information of F0 generation C. elegans and lead to avoidance behavior learned from F1 generation to F4 generation. However, at F5 generation, the avoidance behavior is not observed and the behavior change back to F0 generation again. </p><p><strong>Experiment Result</strong> </p><ol><li><p>Learning the avoidance behavior will pass transgenerically through the TEI method and the avoidance behavior is specific to certain bacteria, that is PA14, but no response to other pseudomonas like S. marcescens. The train of behavior learning is presented through C. elegansâ€™ apparent inclination to OP50 after exposure to PA14 compare to the naturally inclination to PA14 without any previous expose. The PA14 trained C. elegan show higher choice index towards OP50 for both 4 hour and 24 hour compare to control group. OP50 is harmless bacteria type for C. elegan to ingest. </p><img src="/2025/06/19/paper-interpretation-1/control.png" class="" title="this is a testing image"></li><li><p>The avoidance behavior will pass no matter from maternal side or paternal side, both male and female germline demonstrate learned avoidance behavior after initial exposure. However, the learned avoidance only present with 4 generations and no apparent different is observed in the 5th generation. </p><img src="/2025/06/19/paper-interpretation-1/generation.png" class="" title="this is a testing image"></li><li><p>Further detail indicates that the trait demonstration required DAF-7&#x2F;TGF-b presence and also ASI neurone. Apparent upregulation for ASI neuron is presented from F0 to F4 generation and if daf-7 gene is treated with RNAi or the C. elegan carries the mutant version, no different is observed when comparing the PA14 trained group and OP50 trained group. </p><img src="/2025/06/19/paper-interpretation-1/ASI.png" class="" title="this is a testing image"></li><li><p>Other indication, piRNA demonstrate more downregulation(466) compare to upregulation(254). The piRNA is determined to be critical for the trait to transmit to the next generation, the absence of piRNA in F1 generation appear similar preference between two groups.</p><img src="/2025/06/19/paper-interpretation-1/piRNA.png" class="" title="this is a testing image"></li></ol><p><strong>Possible Mechanism</strong></p><p>Based on the analysis of the researchers, the whole transmission process can be categorized into three steps: naÃ¯ve preference, learn avoidance and transgenerational inheritance. Based on the table, one particular gene family is responsible for the naÃ¯ve preference, some for learned while another for transgenerational inheritance.</p><img src="/2025/06/19/paper-interpretation-1/mechanism.png" class="" title="this is a testing image"><img src="/2025/06/19/paper-interpretation-1/table.png" class="" title="this is a testing image"><p>Importance and Impact</p><p>The discovery that transgenerational learned pathogenic avoidance is mediated by Piwi&#x2F;PRG-1 Argonaute and TGF-Î² signaling is a significant advance in the knowledge of environmental experiences on heredity and behavior. The study provides significant insight into the molecular mechanisms through which animals, such as Caenorhabditis elegans, are able to inherit behavioral responses to pathogens without any change in their DNA sequence. The involvement of Piwi&#x2F;PRG-1, a protein already involved in epigenetic regulation by small RNAs, is suggestive of RNA-mediated encoding of transgenerational memory. That TGF-Î² signaling is involved highlights the intersection of classical developmental pathways and adaptive behavioral plasticity.</p><p>This mechanism of inheritanceâ€”bypassing genetic mutation but providing stable phenotypic changeâ€”has profound implications. It challenges traditional boundaries between innate and learned responses and underscores the evolutionary advantage of transmitting adaptive reactions to offspring. The findings not only rewrite the definition of inheritance but also have broader implications for fields ranging from neurobiology to disease treatment. If similar mechanisms are present in more complex organisms, it could have implications for studies on the heritability of stress responses, immune priming, or even trauma.</p><p>In effect, this study links molecular biology, neurogenetics, and evolution, suggesting a compelling example of how behavior and experience may affect lineage survival by inheritance that is not genetic in character. The paper emphasizes the part of epigenetic mechanisms in characterizing organismal adaptation and opens up new possibilities for discovering how life experiences can exert long-term biological consequences for generations.</p><p>Moore, R. S., Kaletsky, R., &amp; Murphy, C. T. (2019). Piwi&#x2F;PRG-1 Argonaute and TGF-Î² Mediate Transgenerational Learned Pathogenic Avoidance. <em>Cell</em>, <em>177</em>(7), 1827-1841.e1812. <a href="https://doi.org/10.1016/j.cell.2019.05.024">https://doi.org/10.1016/j.cell.2019.05.024</a></p>]]></content>
    
    
    <categories>
      
      <category>paper_interpretation</category>
      
    </categories>
    
    
  </entry>
  
  
  
  <entry>
    <title>for some testing</title>
    <link href="/2025/06/18/typora%20hexo%20testing/"/>
    <url>/2025/06/18/typora%20hexo%20testing/</url>
    
    <content type="html"><![CDATA[<p>How does an entire encyclopedia fit inside a pinhead? How does your computer store thousands of files while letting you open any in an instant? The packaging of DNA in your cells accomplishes an even more astonishing feat - fitting 2 meters of DNA into a nucleus smaller than a speck of dust, while keeping every genetic instruction perfectly organized and instantly accessible!</p><p>The magic begins with <strong>nucleosomes</strong> - natureâ€™s ingenious solution resembling tiny sewing spools. Each spool contains eight histone proteins (two each of H2A, H2B, H3, H4), with positively charged amino acids (lysine and arginine) gripping the negatively charged DNA like powerful magnets. Histone H1 acts like a safety clasp, securing the DNA ends to prevent unraveling - much like the plastic tips on shoelaces that keep them from fraying.</p><p>These nucleosome spools then coil into a <strong>30-nanometer fiber</strong>, resembling a tightly wound spring. During normal cell activity, these springs form <strong>300-nanometer loops</strong> anchored to the nuclear scaffold - imagine different colored threads neatly arranged on a giant spool to prevent tangling. When cells prepare to divide, this genetic thread supercoils into visible <strong>metaphase chromosomes</strong>, compacting DNA with the efficiency of fitting an entire skyscraperâ€™s worth of blueprints into a single filing cabinet!</p><p>This packaging system serves as natureâ€™s ultimate <strong>information management system</strong>. Loosely packed <strong>euchromatin</strong> (like an open notebook) allows easy access to genetic instructions, while tightly packed <strong>heterochromatin</strong> (like a locked safe) keeps unnecessary genes silent. Itâ€™s the perfect balance - extreme compression with instant access, much like how modern computers use sophisticated algorithms to store vast amounts of data while maintaining lightning-fast retrieval.</p><p>This sophisticated packaging system demonstrates how cells masterfully balance DNA compaction with functional accessibility, ensuring both genetic stability and precise regulation of gene expression. Biology, thatâ€™s the magic.</p>]]></content>
    
    
    
  </entry>
  
  
  
  <entry>
    <title>Hello World</title>
    <link href="/2025/05/31/hello-world/"/>
    <url>/2025/05/31/hello-world/</url>
    
    <content type="html"><![CDATA[<p>Welcome to <a href="https://hexo.io/">Hexo</a>! This is your very first post. Check <a href="https://hexo.io/docs/">documentation</a> for more info. If you get any problems when using Hexo, you can find the answer in <a href="https://hexo.io/docs/troubleshooting.html">troubleshooting</a> or you can ask me on <a href="https://github.com/hexojs/hexo/issues">GitHub</a>.</p><h2 id="Quick-Start"><a href="#Quick-Start" class="headerlink" title="Quick Start"></a>Quick Start</h2><h3 id="Create-a-new-post"><a href="#Create-a-new-post" class="headerlink" title="Create a new post"></a>Create a new post</h3><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br></pre></td><td class="code"><pre><code class="hljs bash">$ hexo new <span class="hljs-string">&quot;My New Post&quot;</span><br></code></pre></td></tr></table></figure><p>More info: <a href="https://hexo.io/docs/writing.html">Writing</a></p><h3 id="Run-server"><a href="#Run-server" class="headerlink" title="Run server"></a>Run server</h3><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br></pre></td><td class="code"><pre><code class="hljs bash">$ hexo server<br></code></pre></td></tr></table></figure><p>More info: <a href="https://hexo.io/docs/server.html">Server</a></p><h3 id="Generate-static-files"><a href="#Generate-static-files" class="headerlink" title="Generate static files"></a>Generate static files</h3><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br></pre></td><td class="code"><pre><code class="hljs bash">$ hexo generate<br></code></pre></td></tr></table></figure><p>More info: <a href="https://hexo.io/docs/generating.html">Generating</a></p><h3 id="Deploy-to-remote-sites"><a href="#Deploy-to-remote-sites" class="headerlink" title="Deploy to remote sites"></a>Deploy to remote sites</h3><figure class="highlight bash"><table><tr><td class="gutter"><pre><span class="line">1</span><br></pre></td><td class="code"><pre><code class="hljs bash">$ hexo deploy<br></code></pre></td></tr></table></figure><p>More info: <a href="https://hexo.io/docs/one-command-deployment.html">Deployment</a></p>]]></content>
    
    
    
  </entry>
  
  
  
  
</search>
